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The actin cytoskeleton is a dynamic machine that constantly undergoes rearrangements 
to perform diverse cellular functions, which range from powering movement to providing 
mechanical strength and shape. Actin function is regulated by numerous actin-binding 
proteins (ABPs) that modulate its polymerization kinetics and interactions with other cellular 
components. The gelsolin superfamily of calcium-dependent ABPs, are multifunctional 
regulators of actin dynamics that participate in numerous cellular processes. Calcium binding, 
to the six conserved type-II sites, activates gelsolin by inducing large structural 
rearrangements that expose the actin-binding sites. Gelsolin can then bind monomeric actin or 
sever, cap and nucleate filaments. However, the mechanisms through which calcium binding 
is translated into large domain movements, and the contribution of the individual type-II sites, 
remain unclear.  
This thesis describes the structures of the actin-bound N-terminal half (G1-G3) and 
active domain-3 (G3) of human cytoplasmic gelsolin. These data, in combination with the 
functional characterization of calcium-binding site mutants of gelsolin, provide insights into 
gelsolin activation. Release of the C-terminal tail-latch partially activates gelsolin, by 
allowing it to dynamically shift between open and closed conformations, and appears to be 
one of the early steps of activation. Cooperative binding of calcium to domains 2 (G2) and 6 
(G6) mediates tail-latch release by inducing localized structural changes, possibly resulting in 
clashes that push these two domains apart. Cooperative binding of calcium to G2, G4 and G6 
or G2, G5 and G6, appear to activate the C-terminal half of gelsolin (G4-G6) by springing the 
G4-G6 latch in addition to the tail-latch.  
The role of the gelsolin mutations, studied here, has relevance for familial amyloidosis 
of the Finnish-type (FAF). The G2 mutation causing FAF was observed to be activating at 
low calcium concentrations and had a destabilizing effect at high calcium concentrations. 
Thus, mutant gelsolin possibly gets trapped in intermediate conformations where the furin 
cleavage site is exposed and gets cleaved into the deposit-forming fragments.  
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The functional characterization studies of adseverin, presented here, suggest that the 
C-terminal half of human adseverin (A4-A6) is indistinguishable from that of G4-G6, placing 
the major actin-binding site of A4-A6 within A4. A5-A6 lacks any ability to nucleate actin 
polymerization. However, while the isolated G1-G3 has calcium-independent activity, the 
adseverin N-terminal half (A1-A3) must bind calcium to function, thus explaining why 
adseverin is inactive in the absence of calcium, despite the lack of the C-terminal tail-latch. It 
appears that calcium-independent activity of isolated G1-G3 may be attributed to 
conformational changes induced by the binding of actin to G2 and the straightening of the G3 
helix and AB loops.  
Finally, the structure of calcium-free full-length zebrafish scinderin-like B (scinlB) 
was elucidated and observed to be broadly similar to the structure human gelsolin. However, 
despite being calcium-free, the structure of scinlB appears to be in an early activation stage, 
possibly because it crystallized at a semi-activating pH. This structure suggests that calcium- 
and pH-dependent activation may share some common mechanisms, and also offers an 
avenue for elucidating pH-mediated activation of gelsolin family proteins.  
Hence, this study has elucidated some of the mechanisms involved in calcium-
activation of gelsolin-family members, delineated the roles of the G2, G4, G5 and G6 type-II 
calcium-binding sites in activation, highlighted the functional similarities and differences 
between gelsolin and adseverin, and provided avenues for further exploration of the roles and 
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Chapter 1. Introduction 
1.1 Introductory Remarks 
Microfilaments, one of the three protein systems that constitute the cytoskeleton, are 
dynamic linear assemblies of actin that constantly undergo rearrangements in order to provide 
cells with structure, shape and movement. The synchronized polymerization and 
depolymerization of actin filaments contribute to the force required for eukaryotic cellular 
movement, whereas complex networks of filaments provide mechanical strength. Since the 
discovery of actin, more than 300 proteins that regulate actin function in various cellular 
processes have been identified and many of their mechanisms of action have been analyzed 
(Siripala and Welch, 2007a). However, the dynamic nature that permits the actin cytoskeleton 
to play diverse roles within the cell also adds layers of complexity that hinder the complete 
elucidation of the mechanism of function and regulation of the actin network. Technical 
advancements that engender live cell imaging and thus allow us to label and visualize specific 
molecules in vivo, in combination with interactomics will perhaps provide a bird’s eye view 
of the interplay between the multitudes of factors that influence actin function. However, an 
in-depth understanding of the interactions between actin and specific actin-binding proteins 
(ABPs) and their mechanism of action relies upon structural, biophysical and biochemical 
approaches. 
In this work, an attempt has been made to better understand the activation and 
function of gelsolin and adseverin. The similarities between these proteins highlight 
mechanisms that are common across the gelsolin family, while their differences offer insights 
into mechanisms that fine-tune their activity in accordance with cellular requirements. Since 
the function of the gelsolin family proteins is influenced by the inherent characteristics of 
actin, as well as the function of other ABPs, it is necessary to briefly explicate what is known 
about actin and various ABPs before delving into the gelsolin family. 
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1.2 Actin – custom made cellular infrastructure 
Actin was first discovered as part of the actomyosin complex from muscle tissues 
(Straub, 1942). The role of actin in muscle contraction was established soon after. Since then, 
actin has been found to be ubiquitously expressed in all eukaryotic cells. Although actin itself 
is not present in prokaryotes, actin-like proteins that are putative ancestors with similarities in 
structure and function have been identified (Jones et al., 2001; Moller-Jensen et al., 2002; van 
den Ent and Lowe, 2000).  
There exists 95% identity between amoeba and vertebrate isoforms of actin. This 
exceptional degree of sequence conservation and many common binding partners are a 
testament to its crucial cellular role. Actin is essential for the survival of most cell types and is 
the most abundant amongst cytoplasmic proteins making up nearly 20% of the total protein in 
striated muscles (Sheterline et al., 1998, reviewed in dos Remedios et al., 2003). Significant 
quantities of actin are also present in non-muscle cells (65-70 µM, Bamburg and Drubin, 
1999), where it plays diverse roles, some of which are described in Sections 1.2.1 and 1.2.2. 
Actin has six nearly identical, species-independent isoforms with variable expression 
(Vandekerckhove and Weber, 1978). They are α-smooth, α-cardiac, α-skeletal (expressed in 
various muscle cells), β-cytoplasmic (expressed in non-muscle cells), γ-cytoplasmic and γ-
smooth (expressed in non-muscle and smooth muscle cells). Much of our understanding of 
actin structure, dynamics, and interactions with other proteins is drawn from in vitro studies 
conducted on skeletal α-actin. 
Within the cell, actin exists in dynamic equilibrium between the monomeric form (G-
actin) and the filamentous form (F-actin). Actin filaments are reorganized into structures of 
varying complexity and transience in response to a variety of cues, both from within and 
outside the cell (Fig. 1.1). The combination of strength, flexibility and sensitivity makes actin 
a versatile cellular component capable of transforming from one structure to another to meet 
cellular demands.  
 














1.2.1 Actin functions in the cytoplasm 
For almost two decades after discovery, actin was believed to be exclusively involved 
in muscle contraction. It was later discovered that movements resulting from the interaction 
between myosin motor proteins and actin have more diverse effects, such as pinching during 
cell division to produce daughter cells, the retraction of the rear of a moving cell, and 
shuttling of cargo along actin tracks (Fig. 1.2, reviewed in Pollard and Cooper, 2009). Actin-
based cell movement is responsible for cell migration during development, morphogenesis 
and metastasis (reviewed in Jiang et al., 2009; Ren et al., 2009). Actin filaments form 
specialized higher order structures through interactions with assorted binding partners. 
Structures such as acrosomal bundles of sperm (Tilney et al., 1973), micro-villi on the brush-
border cells lining the intestine (Tilney and Mooseker, 1971), and perinuclear caps (Khatau et 
Figure 1.1. Micrographs of actin filament structures in cells. (A) Fluorescence light 
micrograph of an animal epithelial cell grown in tissue culture and infected with a 
bacterium, Listeria monocytogenes. Actin filaments are red and bacteria are green. Actin 
bundles called stress fibers, which bridge sites of adhesion to the substrate, are visible. 
The bacteria use arp2/3 complexes to assemble comet tails for transport through the 
cytoplasm. (B) Electron micrograph of three types of cytoskeletal polymers in a cell 
permeabilized to release soluble components. After rapid freezing, the frozen water was 
sublimed away and cellular components were coated with platinum. Red colorization 
highlights a microtubule. A bundle of actin filaments and a network of intermediate 
filaments are labeled. (C) Electron micrograph of the network of branched actin filaments 
at the leading edge (top) of a motile keratocyte. The cell was grown in tissue culture, 
extracted to release soluble materials, dried, and coated with platinum.  Reproduced from 
Pollard and Cooper, 2009. 
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al., 2009) serve as cellular scaffolding, providing force for movement, mechanical strength 
and shape to cells and organelles, maintaining the viscoelasticity of the cytoplasm and 
positioning organelles within the cell. An intriguing example is the role of actin in the control 
of spindle positioning, spindle anchoring to the cortex and cortical differentiation during the 











Figure 1.2. Cartoons showing actin-based movements. (A) Clathrin-mediated endocytosis 
at fungal actin patches. (B) Formation of branched filament networks nucleated by arp2/3 
complex, which is used for three of these types of movement, those depicted in (A), (F), 
and (G). (C) Transport of membrane-bound vesicles, organelles, and RNAs from the 
mother cell to the daughter cell by class V myosins in budding yeast. (D) Cytokinesis in 
animal cells by constriction of a contractile ring of actin filaments and myosin II. (E) 
Cytokinesis in fission yeast. The contractile ring of actin filaments and myosin II forms by 
condensation of nodes. (F) The Listeria bacterium stimulates the assembly of an actin 
filament comet tail to push it through the cytoplasm of a host animal cell. (G) Locomotion 
of an animal cell by assembly of actin filaments at the leading edge and retraction of the 
tail. Reproduced from Pollard and Cooper, 2009, with permission from AAAS. 
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Besides cell movement and scaffolding, the actin cytoskeleton participates in ion-
channel activity, secretion, membrane trafficking, ageing, apoptosis and cell survival 
(Gourlay and Ayscough, 2005; Papakonstanti and Stournaras, 2008). Actin superstructures 
such as bundles, stress-fibers and branched networks form the core of cell-cell adhesion and 
cell-matrix adhesion structures such as focal adhesions, podosomes and invadosomes, which 
determine barrier functions and invasiveness of cells  (reviewed in Albiges-Rizo et al., 2009; 
Ren et al., 2009). In the case of specialized cells such as podocytes of the renal glomerulus, 
the precise organization of the actin cytoskeleton is responsible for the maintenance of the 
filtration barrier (reviewed in Faul et al., 2007). While this is by no means a comprehensive 
description of the cellular processes that are actin-dependent, it provides some idea of the 
range of functions that the actin cytoskeleton performs within the cell. Additional, functions 
performed by nuclear actin are summarized below. 
 
1.2.2 Actin functions in the nucleus 
Despite initial controversy about the presence of actin in the nucleus, there has been 
mounting evidence in the last few years for the nuclear presence and function of actin. Studies 
indicate that nuclear actin exists primarily in highly dynamic, monomeric or short oligomeric 
conformations (Gonsior et al., 1999; McDonald et al., 2006). G-actin can enter and exit the 
nucleoplasm by diffusion despite being at the edge of the exclusion limit of the nuclear pore 
complex, and also has conserved nuclear export signals that are recognized by exportin 1 
(Weis, 1998). Members of various families of ABPs that have been detected in the nucleus 
regulate the dynamics of nuclear actin (reviewed in Gieni and Hendzel, 2009). Actin serves as 
a cofactor in gene regulation by the serum response factor (SRF) signaling pathway by 
sequestering ML1/myocardin-related transcription factor A (MAL) within the cytoplasm or 
powering the export of MAL from the nucleoplasm by forming a complex (Guettler et al., 
2008; Vartiainen et al., 2007). Thus cytoplasmic F-actin formation and consequent depletion 
of nuclear actin are pre-requisites for the transcription of SRF/MAL responsive genes. As a 
subunit of various chromatin-remodeling complexes, actin is involved in nucleosome 
Chapter 1. Introduction 
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movement, histone acetylation and exchange of histone variants within nucleosomes 
(reviewed in Olave et al., 2002). Actin also participates in global transcription as part of the 
transcription factor TFIIIC complex, and in association with the RNA polymerases. More 
recently, polymeric nuclear actin has been implicated in the directed movement, organization 
and regulation of chromatin within the nucleus (reviewed in Gieni and Hendzel, 2009). 
Evidence of nuclear functions requiring polymeric actin combined with reports of the lack of 
interaction of phalloidin with any intra-nuclear structures suggest that actin adopts 
conformations within the nucleus that are different from those present in the cytoplasm. 
 
1.2.3 In the X-ray beam – the structure of actin  
1.2.3.1 G-actin 
The structure of G-actin was first determined in complex with DNaseI (Kabsch et al., 
1990). Since then, numerous structures of G-actin from different species have been elucidated 
in an effort to put together the pieces of the enormous puzzle that is the actin cytoskeletal 
network. These structures include chemically modified (Otterbein et al., 2001) or cross-linked 
actin (Bubb et al., 2002; Kudryashov et al., 2005; Reutzel et al., 2004) or G-actin in complex 
with various binding partners inclusive of ABPs or domains thereof, small molecule toxins 
such as latrunculin and cytochalasin D and ligands such as ADP, Mg-ATP and Ca-ATP.  
The 375 residue actin polypeptide adopts a globular tertiary structure that can be 
subdivided into the large and small domains, each of which can be further subdivided into 
two domains yielding a total of four subdomains – I (residues 1-32, 70-144, 338-375), II (33-
69), III (145-180, 270-337) and IV (181-269) (Fig. 1.3). The exposed interfaces of 
subdomains 1 and 3, and subdomains 2 and 4 are named the barbed and pointed ends 
respectively, in accordance with the appearance of myosin-actin in electron micrographs 
(Huxley 1963, Moore, Huxley and DeRosier 1970). 
The small and large domains are separated by a deep cleft. The α-helix (Ile-136 to 
Gly-146) at the base of the cleft connects the two domains and forms a flexible hinge that 
allows movement of the domains with respect to each other (Tirion and Benavraham 1993). 
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The cleft contains nucleotide and cation binding sites that are preferentially occupied by ATP 
or ADP-Pi, rather than ADP, due to differences in affinity; G-actin, Mg-G-actin and Ca-G- 
have a 3-fold, 4-fold and 200-fold higher affinity for ATP relative to ADP (Kinosian et al., 
1993). The high intracellular magnesium concentration dictates that Mg2+ occupies the metal 
affinity site, in vivo (Gershman et al., 1986; Herz et al., 1969; Kitazawa et al., 1982). 
However, in vitro, Ca2+ from the buffers used to prepare actin, resides at this site (Gershman 
et al., 1986). The nucleotide-cation complex within the cleft interacts with residues from both 
domains thus stabilizing the native conformation of the protein (Barany et al., 1961; Kinosian 











The natural heterogeneity in filament length has precluded the crystallization of F-
actin, and therefore, the determination of the structure of actin filaments at atomic resolution. 
Figure 1.3. Structure of G-actin. Chemically modified G-actin (PDB ID 1J6Z) is bound to 
ADP-Ca. The four subdomains are labeled 1 through 4. ADP is shown in stick 
representation and calcium is displayed as a blue sphere. 
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However, an understanding of the structure of F-actin and the interactions of various proteins 
with the filament is mandatory for elucidating the mechanism of function and regulation of 
the actin cytoskeleton. Therefore, numerous attempts have been made to circumvent this 
problem and structurally characterize F-actin. The first notable atomic model of F-actin was 
obtained, by the analysis of the X-ray fiber diffraction pattern of oriented actin gels (Holmes 
et al., 1990) and further refined (Lorenz et al., 2007) to yield the widely accepted Holmes 
model of F-actin. The actin filament was determined to be a helical polymer with 13 
molecules and six left-handed turns per 360° repeat. Each subunit has a rotation of -166°, and 
a pitch of 59 Å. Due to this rotation, F-actin can appear morphologically as either a single 
left-handed helix or two intertwined right-handed helices. While this low-resolution model 
placed the actin monomer in the filament, it was unable to account for conformational 










Figure 1.4. Transition from G- to F-actin. (A) Front view. The subunit of the F-actin model 
(pink) and the TMR–actin crystal structure (green cyan; PDB code 1J6Z) are superimposed 
on subdomains 1 and 2. The rotational axis about which subdomains 3 and 4 are rotated with 
respect to subdomains 1 and 2, and the direction of rotation are indicated by the red line and 
red arrow, respectively. The rotation is associated with bends of the polypeptide chain at 
residues 141–142 and 336–337, that are indicated in blue. (B) Side view, viewed from the 
left-hand side of subdomains 3 and 4 in A. Subdomains 1 and 2 are not displayed for the 
sake of clarity. 
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The recent high-resolution model for F-actin (Oda et al., 2009) offers insights into the 
conformational changes that occur during actin polymerization. There are a couple of 
significant differences between G- and F-actin subunits (Fig. 1.4). First, the major domains of 
the actin monomer within the filament display a relative 20° rotation that flattens the F-actin 
subunit in comparison with G-actin. Secondly, the D-loop in subdomain 2, which is usually 
disordered in the G-actin conformation, adopts an ordered open loop conformation in the 
filamentous form.  
The new model of F-actin has contributed significantly to the collective 
understanding of the mechanisms of polymerization. However, the conformation and 
assembly of F-actin varies with the isoforms of actin (Orlova et al., 1997; Orlova and 
Egelman, 1995), bound cation, nucleotide or actin-binding protein (McGough et al., 1997; 
Owen and DeRosier, 1993), resulting in the dynamic, flexible and versatile nature of F-actin.  
 
1.2.4 Actin dynamics 
F-actin assembly is a multi-step process that begins when the concentration of G-actin 
exceeds the critical concentration (CC), which is defined as the concentration of monomers 
that coexists with the polymeric form at steady state (Kasai et al., 1962; Oosawa et al., 1959). 
The CC depends on solvent conditions and varies with type and concentration of salts, ionic 
strength, pH, and temperature (reviewed in Chhabra and dos Remedios, 2007). Within the 
cell, ABPs sequester actin monomers so that cellular concentrations of G-actin can be up to 
1000 times in excess of the in vitro CC (Pollard et al., 2000). 
Actin polymerization has been described as a condensation reaction consisting of four 
steps, namely, activation, nucleation, elongation and annealing (Fig. 1.5, Cooper et al., 1983a; 
Gaszner et al., 1999; Pollard, 1986a). G-actin is activated when the binding of cations 
neutralizes negative charges and reduces electrostatic repulsion between monomers (Carlier 
and Pantaloni, 1986; Carlier et al., 1986; Frieden and Goddette, 1983). Activated G-actin is 
nucleation competent. However, this is an energetically unfavorable process requiring the 
binding of monomers to form a stable oligomer, and is therefore, the rate-limiting step in actin 
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polymerization (Wegner and Engel, 1975). The nuclei composed of short stable oligomers of 
actin are then elongated by the addition of monomeric actin at both ends. Newly added 
protomers undergo conformational changes that anneal them with the filament. Actin 
filaments are polar molecules that have different CC as well as association and dissociation 
rates at each end (pointed end: CC= 0.6 µM, association rate in ATP 0.5 µM/s, dissociation 
rate in ATP 1 µM/s; barbed end: CC= 0.1 µM, association rate in ATP 5 µM/s, dissociation 
rate in ATP 1 µM/s; (Pollard, 1986b, reviewed in dos Remedios et al., 2003). Consequently, 
at steady state in the presence of ATP, association occurs predominantly at the barbed end and 
dissociation at the pointed end resulting in near unidirectional growth of the actin filament, in 
a process termed treadmilling (Wegner, 1976). Treadmilling generates the force required for 














1.2.5 Regulation of actin dynamics – The role of actin binding proteins 
ABPs govern the temporal and spatial accuracy of actin cytoskeletal rearrangements 
in order to ensure that cellular processes dependent on the actin network are orchestrated 
Figure 1.5. Spontaneous formation of F-actin. Spontaneous nucleation and elongation. Dimers 
and trimers are unstable. Longer polymers grow rapidly at the barbed end (B) and slowly at 
the pointed end (P). Pointed end: Cc= 0.6 µM, association rate in ATP 0.5 µM/s, dissociation 
rate in ATP 1 µM/s; barbed end: Cc= 0.1 µM, association rate in ATP 5 µM/s, dissociation 
rate in ATP 1 µM/s; Pollard, 1986. Reproduced from Pollard and Cooper, 2009, with 
permission from AAAS. 
Chapter 1. Introduction 
 11 
smoothly. ABPs alter the kinetics of actin polymerization and the interactions between the 
actin network and other cellular components (Fig. 1.6). At the molecular level, they nucleate 
filaments, cap them specifically at their pointed or barbed ends, cross-link them to form 
bundles or networks, stabilize them, disassemble them by depolymerization or severing, 
promote nucleotide exchange or sequester monomeric actin. Many ABPs display multiple, 
overlapping or redundant functions in a possible attempt to ensure that the cytoskeletal 
machinery is fail-safe. 
ABPs themselves respond to various cues that range from downstream messengers of 
signaling cascades, such as divalent cations or small GTPases (Disanza et al., 2005) to 
modifications such as phosphorylation or competition with other interacting partners of actin. 
Thus, in response to a variety of intra- and extra-cellular stimuli, ABPs alter the local 
structure of the actin cytoskeleton to suit the needs of the cell. 
ABPs have been previously classified on the basis of their actin-modulatory functions  
their evolutionary families, or the cellular processes that they influence (dos Remedios et al., 
2003; Siripala and Welch, 2007a, b). Some human ABPs are listed in Table 1.1 along with an 
example of an actin-modulatory function each.  
 
1.3 The gelsolin superfamily 
1.3.1 Overview 
The gelsolin superfamily proteins (GSPs) are calcium-dependent modulators of actin 
dynamics, expressed in all higher eukaryotes. These proteins have been identified across 
diverse species and are delineated as a family based on similarities in sequence and domain 
architecture. GSPs have multiple repeats of a conserved gelsolin domain that is 100 – 125 
residues long and folds into a 5- or 6-stranded β-sheet sandwiched between a long helix that is 
parallel, and a short helix that is perpendicular to the sheet (Fig. 1.7, Burtnick et al., 1997; 
McLaughlin et al., 1993). GSPs are multifunctional, boasting a vast repository of actin-related 
functions. They can sever, cap, nucleate and bundle filaments and sequester monomeric 
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Table 1.1 Some human ABPs with an example of their functions 
Protein Family Biochemical Function 
Actin Nucleators 
Formins associates with barbed ends, promotes nucleation 
Spir nucleates unbranched filaments 
Arp2/3 complex polymerizes Y-branched filament networks 
G-Actin Binding Proteins 
CAP/Srv2 recycles actin monomers 
Profilin prevents actin monomer addition at pointed ends 
DnaseI sequesters G-actin 
Thymosin β4 sequesters G-actin 
Verprolin/WIP binds actin monomers, WASP 
F-Actin Binding Proteins 
Ena/VASP family antagonizes CapZ capping at filament ends, recruits profilin 
MIM binds both G- and F-actin, may regulate nucleation-promoting factors 
Pointed End Capping Proteins 
Tropomodulin/Tmod caps pointed ends, binds tropomyosin 
Barbed End Capping Proteins 
AIP1 promotes depolymerization by ADF/cofilin 
CapG caps barbed ends (calcium-dependent) 
capping protein heterodimer that caps barbed ends 
Eps8 caps barbed ends, involved in Rac signalling 
Actin Depolymerizing/Severing Proteins 
ADF/cofilin promotes actin filament assembly and  disassembly 
Gelsolin/villin superfamily severs actin filaments 
Twinfilin inhibits actin nucleotide exchange 
Actin/Bundling/Crosslinking Proteins 
α-actinin connects and organizes actin filaments 
EPLIN stabilizes and bundles actin filaments 
Espin forms parallel actin bundles 
Fascin bundles actin filaments 
Filamin orthogonally cross-links actin filaments 
Fimbrin/plastin bundles actin filaments 
 
 












Figure 1.6. Roles of actin binding proteins in actin dynamics. (A) Actin monomer binding 
proteins. Thymosin-β4 blocks all assembly reactions; profilin promotes nucleotide 
exchange and inhibits pointed-end elongation and nucleation; cofilin inhibits nucleotide 
exchange and promotes nucleation. (B) Nucleation and elongation by formins. Formins 
initiate polymerization from free actin monomers and remain associated with the growing 
barbed end. Profilin-actin binds to formin and adds actin to the barbed end of the filament. 
(C) Nucleation by arp2/3 complex. Nucleation-promoting factors such as WASp bind an 
actin monomer and arp2/3 complex. The barbed end of the daughter filament grows from 
arp2/3 complex. (D) Reactions of actin filaments. Capping proteins bind to and block 
barbed ends; cofilin and gelsolin sever filaments; cross-linking proteins assemble networks 
and bundles of actin filaments. (E) Myosin motors, such as myosin V, use cycles of ATP 
hydrolysis to walk along actin filaments, generally toward the barbed end. Reproduced with 
from Pollard and Cooper, 2009, with permission from AAAS. 
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actin. Differences in their actin regulatory functions ensue from minor sequence variations 
that also ensure that these proteins respond to different cellular cues. Ancillary functions or 
actin regulatory activities are also conferred on certain members by additional N- or C- 
terminal domains. Differential expression patterns introduce another layer of variation in the 











1.3.2 An introduction to gelsolin and its mammalian relatives 
There are seven mammalian members of this family, namely, capG, gelsolin, 
adseverin, villin, advillin, supervillin and flightless I (Fig. 1.8). Amongst them capG has three 
core gelsolin domains while the others have six. Other three-domain proteins, e.g. severin and 
fragmin exist in lower organisms. The preliminary knowledge of only three- and six- domain 
Figure 1.7. Structure of the gelsolin core domain. The typical gelsolin fold is comprised of 
a central β-sheet sandwiched between a long helix that is parallel and a short helix that is 
perpendicular to the sheet. The five strands of the core domain are labeled A through E 
starting from the N-terminal end. The loop between strand A and B is termed the AB loop 
and the loop C-terminal to the long helix is termed the LhCt loop. 
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gelsolin-related proteins led to the belief that the family has evolved from a single domain 
prototype by gene triplication followed by an additional duplication (Kwiatkowski et al., 
1986; Way and Weeds, 1988). Detailed comparison between capG, gelsolin and villin 
(Mishra et al., 1994) as well as the recent discovery of two-, four- and five-domain GSPs in 
invertebrates, however, are evidence of the unexpected complexity of the evolutionary 
pathway resulting in the gelsolin family of proteins (Gloss et al., 2003; Kawamoto et al., 












Gelsolin was the first of this family to be identified because of its ability to transform 
actin from the viscous “gel” to the fluid “sol” form (Yin and Stossel, 1979). As the protein 
Figure 1.8. Gelsolin family proteins from mammals. The protein images were drawn to scale 
using DOG version 1.0 (Jian et al., 2009). The conserved gelsolin domains are labeled from 1 
through 6. Corresponding domains from the different proteins have the same color. Villin and 
supervillin share the C-terminal headpiece (HP) which is absent from the other members of 
the family. Flightless-I straddles two protein families namely, the leucine-rich repeat (LRR) 
family and the gelsolin family. CapG is the only 3-domain member of the family. Advillin 
has a domain architecture that is identical to villin and is therefore, not represented here. 
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central to this study, gelsolin is used as the reference point for comparing the sequences, 
domain architectures and functions of related proteins. Gelsolin has six homologous core 
domains and eight calcium-binding sites that fall into two classes (Burtnick et al., 1997; 
Kwiatkowski et al., 1986). The structure of gelsolin, the calcium-binding sites and the effects 
of calcium binding on the structure and function of the protein are later discussed in depth. 
Like other members of this family, gelsolin has multiple actin related functions and can 
sequester G-actin and cap F-actin at the fast-growing end (Yin et al., 1981; Yin and Stossel, 
1979). Gelsolin is also the most potent F-actin severing protein known, and has been 
demonstrated to nucleate filament formation in vitro (Kurth et al., 1983; Wang and Bryan, 
1981). The wide range of defects observed in gelsolin-null mice has exemplified the 
important role of gelsolin in actin dynamics regulation in vivo. Gelsolin-null dermal 
fibroblasts display reduced ruffling response and translational motility, excessive actin stress 
fibers and increased contractility, while gelsolin-null mice display greater susceptibility to 
glutamate toxicity, decreased platelet shape changes and longer bleeding times (Azuma et al., 
1998; Furukawa et al., 1997; Witke et al., 1995). 
Adseverin is the closest relative of gelsolin sharing a 60% sequence identity and a 
similar six-domain organization. The adseverin sequence differs from that of gelsolin, 
primarily due to the lack of the C-terminal tail latch. This structural difference translates into 
a difference in the calcium regulation of adseverin (Lueck et al., 2000). Adseverin also 
displays limited expression in comparison to gelsolin and is found primarily in neural and 
endocrine tissues (Sakurai et al., 1990). However, like gelsolin, adseverin can cap, sever and 
nucleate actin filaments and sequester actin monomers (Maekawa and Sakai, 1990; Rodriguez 
Del Castillo et al., 1990).  
Villin, a 93 kDa, tissue-specific relative of gelsolin, shares a 50% homology with and 
shows a proteolytic cleavage pattern similar to that of gelsolin (Janmey and Matsudaira, 
1988). Like gelsolin and adseverin, villin has a six-domain architecture but has an additional 
C-terminal domain called the headpiece that is capable of binding F-actin (Arpin et al., 1988; 
Bazari et al., 1988; Bretscher and Weber, 1980; Hesterberg and Weber, 1986; Matsudaira et 
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al., 1985). The headpiece provides villin with the ability to bundle F-actin filaments (George 
et al., 2007) over and above the functions of gelsolin. The headpiece, and sequence variations 
within the core domains engender variations in the mechanism of activation of villin. A 
calcium-dependent hinge mechanism exposes the headpiece during activation (Hesterberg and 
Weber, 1983). Although, like gelsolin, villin has six internal calcium-binding sites, the two 
sites located within domain 1 (V1) are responsible for F-actin capping and severing (Kumar et 
al., 2004; Northrop et al., 1986). Also, in contrast to gelsolin, villin requires micromolar to 
millimolar levels of calcium to function, except when tyrosine phosphorylated, suggesting 
that in physiological conditions tyrosine phosphorylation may be the primary mode of 
regulation of villin activity (Kumar and Khurana, 2004).  
Advillin, a 92 kDa protein, was first identified from a murine brain cDNA library, 
and so named due to the high identity with adseverin and villin at 47% and 59%, respectively. 
The domain architecture of advillin is identical to that of villin (Marks et al., 1998). Although 
these two proteins are least similar at the C-terminal headpiece, the last seven residues of the 
villin headpiece that are critical for binding and bundling actin (Doering and Matsudaira, 
1996; Markus et al., 1997) are conserved in advillin. Predominantly expressed in neurons, 
advillin has been implicated in neurite growth and morphogenesis and axon regeneration 
(Hasegawa et al., 2007; Shibata et al., 2004). 
Supervillin, a 205 kDa protein isolated from bovine neutrophil plasma membranes, is 
an unusual member of the gelsolin family (Pestonjamasp et al., 1997; Wulfkuhle et al., 1999). 
Sequence comparison predicts the presence of five gelsolin-like domains (corresponding to 
gelsolin’s domains 2-6), and a villin-like headpiece in the C-terminal third while the N-
terminal two-thirds comprise a unique domain containing four nuclear localization signals. 
Detailed domain analysis reveals that contrary to the predictions, the gelsolin-like C-terminal 
half binds F-actin weakly, the villin-like headpiece lacks F-actin binding altogether and that 
F-actin binding and actin filament bundling are localized in the novel N-terminal domain 
(Vardar et al., 2002; Wulfkuhle et al., 1999). Supervillin forms the link between membranes 
and the actin cytoskeleton and participates in myogenesis, adhesion, motility and 
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cytoarchitecture at both the nucleus and plasma membrane (Chen et al., 2003; Wulfkuhle et 
al., 1999).  
Flightless-I was originally identified in a Drosophila melanogaster mutant with flight 
defects (Campbell et al., 1993). Comprising six gelsolin-like domains in the C-terminal half 
and a leucine-rich repeat (LRR) in the N-terminal half, Flightless-I straddles two protein 
families, the gelsolin superfamily of actin regulators and the LRR group involved in Ras 
signal transduction (Claudianos and Campbell, 1995; Silacci et al., 2004). Flightless-I was 
shown to play an essential role in the development of mice with deficiency resulting in 
embryonic lethal mutants (Campbell et al., 2002). Abnormalities in the flightless-I gene also 
result in developmental abnormalities in humans and Drosophila (Campbell et al., 1993; 
Chen et al., 1995; Straub et al., 1996).  
CapG, the only three-domain member of the mammalian gelsolin clan, isolated from 
alveolar macrophages, is homologous to the N-terminal half of gelsolin (Southwick and 
DiNubile, 1986). However, divergence in the sequence of two short stretches of amino acid 
sequence render capG incapable of severing actin filaments, although it is an efficient barbed 
end capper (Southwick, 1995). CapG is present in both the nucleus and the cytoplasm (Onoda 
et al., 1993) and has functions in cell differentiation, membrane ruffling, phagocytosis, cell 
invasion and metastasis (De Corte et al., 2004; Onoda et al., 1993; Parikh et al., 2003; Renz 
et al., 2008).  
 
1.3.3 Cellular functions of gelsolin family proteins 
A comprehensive study of the evolution of the gelsolin family has never been 
undertaken and therefore, the causes and the exact course of evolution of the diversity within 
the family are poorly understood. However, the diversification of cellular functions dependent 
on cytoskeletal modulation has probably been the driving force behind the divergence and 
proliferation of the gelsolin family. Hence, it is not remarkable, that the cellular processes that 
GSPs participate in, are as varied as the functions of actin. They include cell motility, ion-
channel regulation, cell signaling, apoptosis, phagocytosis, secretion, platelet activation, and 
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modulation of phospholipase C activity (reviewed in Kwiatkowski, 1999; Silacci et al., 2004; 
Sun et al., 1999; Trifaro et al., 2002). Lately, nuclear hormone receptor-mediated signaling 
(reviewed in Archer et al., 2005), wound repair (Kopecki et al., 2009), cell morphology, cell 
invasion, cell migration, epithelial-to-mesenchymal transition (reviewed in Khurana and 
George, 2008), and regulation of podosomes and cadherin junctions (reviewed in Chellaiah, 
2006; El Sayegh et al., 2007) have made it to the growing list of cellular functions involving 
GSPs. All these processes require the precisely modulated activity of the respective gelsolin 
family protein. It is therefore not surprising that the over- or under-expression or 
misregulation of gelsolin family proteins can result in an array of diseases ranging from 
inflammation to cancer (reviewed in Bucki et al., 2008; Spinardi and Witke, 2007).  
 
1.3.4 Regulation of gelsolin family proteins 
The potent severing activity and the ability of GSPs to influence actin dynamics in 
multiple and sometimes contradictory ways necessitates tight regulation of their function. The 
interplay between several regulatory mechanisms is, therefore, responsible for the flawless 
execution of the many roles of GSPs. Factors that modulate GSP functions include calcium 
concentration, pH, modifications such as phosphorylation, and interactions with various 
proteins and phospholipids (McGough et al., 2003; Sun et al., 1999).  
Phosphorylation is one of the key regulatory mechanisms within the cell. This 
modification also plays an important role in the regulation of GSPs. Tyrosine phosphorylation 
is especially important in the activation of villin. It not only reduces the requirement of 
calcium for the activation of villin but also alters the affinity of villin for actin (Zhai et al., 
2001). Differential serine and threonine phosphorylation patterns serve to distinguish different 
functionally significant isoforms of CapG (Onoda and Yin, 1993). Gelsolin is also known to 
be phosphorylated, in vitro. c-Src has been shown to phosphorylate gelsolin in a PIP2-
dependent manner  but the physiological consequences of this are, as yet, unclear (De Corte et 
al., 1997; Sun et al., 1995).  
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Phospholipids such as phosphoinositides and phosphoserines play a pivotal role in the 
regulation of GSPs and are general regulators of many other ABPs (reviewed in Yin and 
Janmey, 2003). They account for a minor fraction of membrane lipids and participate in the 
transduction of extracellular signals into cytoskeletal rearrangements by modulating the 
activity of various ABPs. Phosphoinositides also serve as scaffold targeting molecules and 
create linkages between the cytoskeleton and the plasma membrane. PIP2 is the most 
abundant of the biphosphorylated phosphoinositides and is a potent negative regulator of the 
gelsolin family that favors actin polymerization (Doi et al., 1991). PIP2 has been suggested to 
compete for the same binding site as actin, thereby weakening the interaction between the 
GSPs and actin (Feng et al., 2001; Janmey et al., 1992; Janmey and Matsudaira, 1988; 
Janmey and Stossel, 1987; Maekawa and Sakai, 1990).  
A number of other interacting partners also regulate the functions of GSPs. ABPs 
such as tropomyosin and caldesmon, GTPases such as N-ras, viral oncoproteins, pathogenic 
invasion proteins such as sipA, and bacterial endotoxins have all been proven to modulate 
gelsolin function (Bucki et al., 2005; Cossart, 2004; Dabrowska et al., 1996; Gunning et al., 
2008; Keller et al., 2007; Lindberg et al., 2008; Osborn et al., 2007; Ramakrishnan et al., 
2004; Takiguchi and Matsumura, 2005).  
Amidst the throngs of modulators of the gelsolin family, perhaps the best studied and 
yet only partially elucidated, is the regulation by changes in cellular calcium concentration 
that can vary over two orders of magnitude (10-7-10-5 M). An increase in the cytoplasmic free 
calcium concentration alters the conformation of GSPs (see Section 1.4.3) and activates them 
by exposing their actin-binding sites (reviewed in Yin, 1989). Low pH reduces the calcium 
concentration required for the activation of gelsolin and adseverin but is not known to affect 
the activity of the other members of the family (Lamb et al., 1993; Lueck et al., 2000). 
Studies indicate however, that the conformational changes induced by alteration of pH differ 
from those induced by calcium, thus emphasizing how poorly these mechanisms are 
understood (Lagarrigue et al., 2003b). 
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1.4 Gelsolin 
1.4.1 Key characteristics unique to gelsolin 
Despite the analogous domain architectures, similar functions, and regulatory 
mechanisms shared by GSPs, knocking out these genes results in defects in actin dynamics, 
thus testifying for their non-redundant, if partially overlapping, natures. Amongst the GSPs, 
gelsolin has distinctive characteristics and physiological functions that make it a fascinating 
molecule. 
Gelsolin has three isoforms, namely cytoplasmic gelsolin, plasma gelsolin and 
gelsolin-3, transcribed from alternative initiation sites of a single gene (Kwiatkowski et al., 
1986; Kwiatkowski et al., 1988; Vouyiouklis and Brophy, 1997). Except for the 25- and 10-
residue N-terminal extensions in plasma gelsolin and gelsolin-3 respectively, as compared to 
cytoplasmic gelsolin, the three isoforms have identical sequences. Nevertheless, they function 
efficiently in the vastly different environments of the plasma, cerebrospinal fluid and 
cytoplasm, respectively. Plasma gelsolin, the only GSP found in the blood plasma, is part of 
the actin-scavenging system that prevents actin, released into the plasma during injury, from 
clogging the microvasculature (Vasconcellos and Lind, 1993). Also distinctive within the 
family, is the physiological role of the isolated N-terminal half of gelsolin. During apoptosis, 
caspase-3 cleaves gelsolin between domains 3 and 4, yielding a calcium-independent, three-
domain, actin-severing protein (Kothakota et al., 1997). Intriguingly, the calcium-
independence of the N-terminal half of gelsolin is not mirrored by any of its three- or six-
domain homologues and attaches to gelsolin a unique role during apoptosis.  
Like all GSPs, loss or mutations in the gelsolin gene, or misregulation of gelsolin 
expression and function can have severe consequences on actin dynamics and result in 
diseases. Unlike the other GSPs however, gelsolin has actin-independent pathological roles. 
For example, gelsolin binds to and inhibits the fibrillization of the amyloid-beta protein and is 
suggested to have an anti-amyloidogenic role in Alzheimer’s disease (reviewed in Chauhan et 
al., 2008). Also, a single mutation in gelsolin – Asp187 to Asn or Tyr – makes plasma 
gelsolin susceptible to cleavage by furin in the golgi apparatus, which sets off a cascade of 
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events that causes Familial Amyloidosis of the Finnish type (FAF), characterized by the 
extracellular deposition of a 71-residue fragment of gelsolin (Maury, 1991). 
 
1.4.2 Modular distribution of gelsolin functions 
The various functional and regulatory motifs of gelsolin are discrete and dispersed 
across the length of the protein (Fig. 1.9). The three major actin-binding sites on G1, G4 and 
G2 (Pope et al., 1991, Pope et al., 1995), bind actin through a stretch of highly homologous 
residues of the structurally conserved long helix (McLaughlin et al., 1993; Pope et al., 1995; 









Figure 1.9. Modular distribution of gelsolin functions. The protein images were drawn to 
scale using DOG version 1.0 (Jian et al., 2009). The various functional domains are colored 
into the grey backbone of the protein. Since the different isoforms of gelsolin are identical 
from residue 26 – 755, these are the residues presented in this figure. All residues are 
numbered according to the plasma gelsolin sequence. The G-actin binding sites determined 
through biochemical analyses are in violet, and those determined from X-ray structures are 
pink (Burtnick et al., 2004) and yellow (Robinson et al., 1999). The conserved aspartate and 
glutamate residues of the calcium-binding sites are labeled. The two type-I aspartates are 
labeled in dark blue. 
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Minor actin-binding sites are also present in the G1-G2 linker, G3 and G6 (Burtnick et al., 
2004; Robinson et al., 1999). G1 and G4-G6 are effective filament cappers that can each 
sequester one actin monomer, and compete for the same site on actin (Pope et al., 1991). The 
interaction of G2 with F-actin has long been considered the first step of severing. However, 
severing activity has been localized to G1 along with the G1-G2 linker (Irobi et al., 2003; 
Kwiatkowski et al., 1989; Way et al., 1992a). The calcium-independent function of the 
gelsolin N-terminal half (G1-G3) and the absolute calcium-dependence of the activity of the 
C-terminal half (G4-G6), indicate that calcium regulation is conferred on gelsolin by its C-
terminal half (Kothakota et al., 1997; Pope et al., 1995). Eight calcium-binding sites modulate 
gelsolin activity and are discussed in detail in Chapters 3 and 4. Gelsolin has three PIP2-
binding sites located within the G1-G2 linker (residues 135-142), the G2 actin-binding site 
(161-169) and the G5-G6 linker (621-634) (Feng et al., 2001; Liepina et al., 2003; Tuominen 
et al., 1999). PIP2 uncaps actin filaments by disrupting the interactions between gelsolin and 
actin (Janmey and Stossel, 1987). The mechanism for PIP2 function is unknown but it is likely 
that PIP2 either alters the conformation of the actin binding site on G2, or displaces actin by 
direct competition (Janmey et al., 1992; Liepina et al., 2003).  
 
1.4.3 Molecular gymnast, crystallographer’s bane – conformational antics of gelsolin 
Of the various regulators that influence gelsolin activation and function, the effects of 
calcium on gelsolin are the most extensively studied. Gelsolin exhibits large, domain 
rearrangements induced by calcium binding. Intriguingly, the structure of the core gelsolin 
domain is not significantly altered during calcium-dependent activation. Instead, binding of 
calcium disrupts pre-existing inter-domain contacts and changes loop structures so that the 
actin-binding sites on the protein are exposed, conferring on gelsolin the ability to bind actin 
and consequently to function as a filament severing, capping or nucleating protein (Burtnick 
et al., 2004; Choe et al., 2002; Kolappan et al., 2003; Wang et al., 2009). Chelation of the 
bound calcium ions by EGTA, in the absence of actin, reverses these conformational changes 
supplying additional proof of the dynamic nature of gelsolin (Ashish et al., 2007; 
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Chumnarnsilpa et al., 2006). In the presence of actin, one calcium ion remains trapped in a 
1:1 actin-gelsolin complex  and cannot be removed by chelation of free-calcium (Bryan and 
Kurth, 1984). However, these complexes can be dissociated by the binding of 
phosphatidylinositol phosphates (PIP or PIP2) (Janmey and Stossel, 1987). 
 
1.4.3.1 Structure of inactive gelsolin 
In the inactive state, gelsolin adopts a compact globular conformation stabilized by 
three ‘latches’, namely, the C-terminal tail latch (formed by interaction of the C-terminal 
helix with the long helix of domain 2), the G1-G3 latch (the continuous β-sheet that runs 
through G1 and G3) and the G4-G6 latch (the continuous β-sheet that runs through G4 and 
G6) (Burtnick et al., 1997; Figs. 1.10A and 1.10B). G6 forms the centerpiece of the globule 
and he other domains are arranged around it. The two halves of gelsolin (G1-G3 and G4-G6) 
have similar pseudoquarternary structures (Fig. 1.10B). The long helices of G3 and G6 are 
kinked to accommodate those of G1 and G4, respectively. When the structures of all six 
domains are compared to each other, the greatest similarity is observed between G1 and G4, 
G2 and G5, and G3 and G6, respectively, as would be expected from their sequence 
alignments (Fig. 1.10C, Choe et al., 2002). In this conformation, all the known actin-binding 
sites, both major (G1, G2, G4), and minor (G3, G6) are obscured and unavailable for 
interaction with actin.  
The dynamic nature of gelsolin has thus far hindered the structural characterization of 
the conformational pathway that the protein travels during activation. However, the available 
structures of the activated halves of gelsolin yield tantalizing snapshots indicative of the range 
of dynamic rearrangement of which gelsolin is capable.  
 
1.4.3.2 Structure of the active C-terminal half of gelsolin  
Calcium binding alters the pseudoquarternary structure of the C-terminal half of 
gelsolin to expose the primary actin binding site on the long helix of G4 and the minor actin-  












interacting site on G6 (Fig. 1.11; Kolappan et al., 2003; Robinson et al., 1999). Binding of 
calcium to the high affinity calcium-binding site on G6 is believed to straighten the kink in 
the long helix of the domain, introduce steric clashes with G4 and thus disrupt the G4-G6 
latch (Choe et al., 2002; Pope et al., 1995; Wang et al., 2009). G6 is then translated by ~ 40 Å 
and rotated by 90° with respect to G4, so all inter-domain contacts between G4 and G6 are 
eliminated and new contacts between G5 and G6 are generated. G5 does not participate in 
actin binding, but instead functions as a bridge between G4 and G6 (Figs. 1.10B and 1.11B). 
G4 binds actin at the binding site for G1 at the interface of subdomains 1 and 3 as expected 
from the previously described competition between G1 and G4-G6 (McLaughlin et al., 1993; 
Pope et al., 1991).  
Figure 1.10. Structure of calcium-free equine plasma gelsolin. (A) Schematic representations 
of the structure of whole gelsolin (PDB ID 1D0N). The upper panel shows a view rotated by 
90° clockwise around the horizontal with respect to the lower panel. The C-terminal 
extension (also known as the tail-latch) is striped orange and black. The domains are colored 
as follows; G1, red; G2, light green; G3, yellow; G4, pink; G5, dark green; and G6, orange. 
(B) The relative organization of G1–G3 and G4–G6. The schematic representation shows the 
N-terminal half (upper panel) and C-terrminal half (lower panel) in approximately the same 
orientation. The continuous β-sheets formed by G1 and G4 with G3 and G6, respectively are 
the G1-G3 and G4-G6 latches, respectively. Linker regions are striped with the colors of the 
linked segments. (C) Schematic representations of the six domains of gelsolin in similar 
orientations. Reproduced with permission from Burtnick et al., 1997. 
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In the presence of calcium G4-G6 adopts the active conformation even in the absence 
of actin irrefutably placing the responsibility for the domain reorganization upon the calcium 
binding events (Fig. 1.11B; Kolappan et al., 2003; Narayan et al., 2003b). Calcium is bound 
to each of the conserved sites irrespective of the presence of actin. The location of the G4 and 
G5 calcium ions at the G4-G5 and G5-G6 interfaces, respectively, locks the protein into the 










1.4.3.3 Structure of the active N-terminal half of equine plasma gelsolin 
The structure of the activated N-terminal half of gelsolin is greatly dissimilar from the  
corresponding inactive structure, but contrary to expectation, also differs from the structure of 
the activated C-terminal half (Fig. 1.11C; Burtnick et al., 2004). The G1-G3 latch is ruptured, 
perhaps through a mechanism identical to that employed in the activation of the C-terminal 
half. Stretching of the G1-G2 linker and shortening of the G2-G3 linker by the formation of a 
helix, results in large rotational and translational movements of G2 and G3, relative to G1 that 
Figure 1.11. Structure of the activated halves of gelsolin. (A) Structure of G4-G6/actin (PDB 
ID 1H1V). (B) Structure of calcium-bound G4-G6 (PDB ID 1P8X) (C) Structure of equine 
G1-G3/actin (PDB ID 1RGI). Calciums are shown as blue spheres. Domain colors are 
continued from Fig. 1.10. 
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creates a new G2-G3 interface, analogous to but significantly different from the G5-G6 
interface. However, in contrast to the C-terminal half, there are no contacts between G2 and 
G1 analogous to those between G4 and G5. G1 is isolated from the other domains and bound 
to the cleft between actin subdomains 1 and 3. The G1-G2 linker is stretched across the 
surface of actin so that G2 forms contacts with actin subdomain 2 and G3 interacts with actin 
subdomain 1. The structure of the activated N-terminal half of gelsolin has not been solved in 
isolation. In the structure of G1-G3 in complex with actin, calcium ions are present in all the 
expected sites, except that in G2.  
 
1.5 F-actin severing by gelsolin 
It is possible to draw some conclusions about the mechanism employed by gelsolin to 
sever actin filaments from the currently available structures (Fig. 1.12). When the G1-
G3/actin is superimposed upon F-actin (Oda et al., 2009) it is clear that G2 is capable of 
forming contacts with subdomain 2 of protomer III and subdomain 1 of the vertically adjacent 
protomer V (Fig. 1.12C). G1 is bound to the cleft between subdomains 1 and 3 of protomer 
III and clashes extensively with the protomer I (Fig. 1.12D). Similarly, when G4-G6/actin is 
superimposed upon F-actin, G4 is bound to protomer IV and exhibits considerable clashes 
with protomer II (Fig. 1.12E). The G3-G4 linker appears likely to run diagonally across the 
actin filament from protomer III to protomer II (Fig. 1.12B), but in the absence of the full-
length structure of active gelsolin, this is open to speculation. 
Thus, it is possible that G2 binds the side of an actin filament and makes contacts 
with two adjacent protomers. The extension of the G1-G2 and G3-G4 linkers allows gelsolin 
to wrap around the filament and position G1 and G4 at their corresponding binding sites. G1 
and G4 then compete with the adjacent actins for the binding site at the cleft between 
subdomains 1 and 3, and sever actin much in the manner of a pair of scissors. One could 
surmise that the increased efficiency of full-length gelsolin when compared to the N-terminal 
half, is analogous to the increased efficiency of a pair of scissors as opposed to a knife. The 
same analogy would also suggest that the G3-G4 linker serves as a joint between the cutting 
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Figure 1.12. Model for the severing of F-actin by gelsolin. (A) Structures of activated 
gelsolin N-terminal half (G1-G3) and C-terminal half (G4-G6) are docked upon the F-actin 
structure (Oda et al., 2009) by superimposing the actin monomers bound to G1-G3 (PDB 
1RGI) and G4-G6 (PDB1H1V) on protomer III and IV of the filament, respectively. (B) The 
filament is rotated 180° compared to A. Red dots mark the position of the terminal residues 
of the G3-G4 linker that are visible in the X-ray structures. (C) Interface of G2 with the actin 
filament. G2 appears to form interactions with two vertically adjacent protomers. This is in 
agreement with studies that demonstrate that G2 binds the side of actin filaments. (D) G1 
bound to protomer III clashes extensively with protomer I. (E) G4 bound to protomer IV 
clashes extensively with protomer II. These clashes suggest that G1 and G4 may sever 
filament by displacing the protomers below the ones that they bind. 
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Rationale for the work presented in this study 
Although gelsolin structure, function and regulation have been studied extensively, 
the elucidation of the structural mechanisms responsible for its activation is far from 
complete. Likewise, the mechanism through which the binding of calcium to the conserved 
sites is translated into the structural rearrangements signifying activation remains unclear.  
In this study, structural and biochemical analyses of human gelsolin and adseverin, 
offer insights into the regulation and mechanism of activation of these proteins. The results 
documented here demonstrate that contrary to established belief, the calcium-dependent 
activation of gelsolin is regulated by both the N- and C-terminal halves, although the 
contribution of the latter may be greater. In contrast, the regulation of adseverin activity 
appears to reside primarily within the N-terminal half. Interestingly, the C-terminal halves of 
these two proteins have similar structures and indistinguishable functions. The structure of the 
zebrafish homolog, scinderin-like B, has been determined and appears to be in an 
intermediate state that offers clues to the structural mechanisms involved in early stages of 
activation. It also suggests that activation of gelsolin family proteins by calcium and pH 
changes share some common mechanisms and that the disordered loop and linker regions of 
these proteins play key roles in the activation process. 
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Chapter 2. Materials and Methods  
2.1 Materials 
Table 2.1 Reagents used in this study 
Description Source 
Laboratory Chemicals Sigma Chemical Company, Calbiochem 
Media Components Novagen 
Antibiotics Sigma, Calbiochem, Fluka 
Protease inhibitor cocktail tablets 
(EDTA free) 
Roche Applied Science 
Plasmid extraction kits Qiagen 
DNA modifying and Restriction 
enzymes 
New England Biolabs  
Roche Applied Science  
Agilent Technologies (Stratagene) 
Crystallization screens Hampton Research  
 
Table 2.2 Oligonucleotides/primers used in this study 
Primer Sequence Source 
GelF1 
























Forward primer for cloning scinlB into pSY5-CDF vector 
5’ ccaggggcccatggtgtcccacaaggagttcacg 
This study 
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ScinlB_R 




























































Forward primer for Glu475Gln mutation in gelsolin domain 4 
5'-cccagtctacccaggatcaggtcgctg 
This study 
E451Q_R Reverse primer for Glu475Gln mutation in gelsolin domain 4 This study 






































2.2.1 Cloning and construct preparation 
2.2.1.1 Vectors used 
pSY5 – Expression vector pSY5 is a modified version of pET-21d(+) (Novagen) that 
encodes an N-terminal, eight-histidine tag, followed by a human rhino-virus 3C protease 
cleavage site ahead of the N-terminus of the protein (Fig. 2.1; Wang et al., 2009). pSY5 
confers ampicillin resistance on transformed cells. 
pSY5-CDF – Expression vector pSY5-CDF is a modified version of pCDFDuet-1 
(Novagen) that encodes an  N-terminal, eight-histidine tag, followed by a human rhino-virus 
3C protease cleavage site ahead of the N-terminus of the protein (Fig. 2.2). pSY5-CDF 
confers streptomycin/spectinomycin resistance on transformed cells. 
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 Figure 2.1. Vector map of pSY5. This expression vector confers resistance to ampicillin. 
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 Figure 2.2. Vector map of pSY5-CDF. This expression vector confers resistance to 
spectinomycin/ streptomycin 
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2.2.1.2 Strains and culture conditions 
E. coli XL1 Blue supercompetent cells (Stratagene) were used as bacterial hosts for 
cloning and plasmid DNA amplification.  The standard transformation protocol specified by 
the manufacturers was used. The E. coli cells were grown either in LB broth (Novagen) or on 
LB agar (Novagen) plates, at 37 °C. 100 µg/ml ampicillin or 50 µg/ml spectinomycin was 
added to the media for selection of cells carrying recombinant plasmids. 
 
2.2.1.3 Cloning of scinlA and scinlB 
Full-length cDNA of ScinlA and scinlB were obtained from Open Biosystems. The 
inserts were amplified and linearized by PCR with primers (ScinlA_F and ScinlA_R for 
scinlA and ScinlB_F and ScinlB_R for scinlB) listed in Table 2.2. Subsequently, the scinlA 
and scinlB inserts were cloned into the pSY5-CDF vector using the LIC cloning protocol. The 
T4 DNA polymerase used in the reactions was obtained from New England Biolabs and 
dATP and dTTP were obtained from Fermentas. 
 
2.2.1.4 Site-directed mutagenesis 
Calcium-binding mutants of gelsolin (listed in Table 4.1) were created using the 
QuikChange site-directed mutagenesis kit (Stratagene) and oligonucleotides listed in Table 
2.2. The primers were designed with Stratagene’s online primer design program 
http://www.stratagene.com/sdmdesigner/default.aspx. 
 
2.2.2 Protein expression and purification 
2.2.2.1 Gelsolin and calcium-binding mutants, scinderin-like A, scinderin-like B 
Constructs of gelsolin and its variants were transformed into E. coli Rosetta 2 (DE3) 
cells (Novagen) for expression according to the manufacturer’s protocol. Overnight cultures 
were prepared by growing the cells in LB liquid media supplemented with 100 µg/ml 
ampicillin and 34 µg/ml chloramphenicol at 37 °C with shaking at 250 rpm for 16 h. Fresh 
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LB liquid media was inoculated with 15 ml of overnight culture per litre, and incubated with 
shaking at 250 rpm at 37 °C until cell density reached OD600 = 1, as measured with an 
Ultrospec10 cell density meter (GE Healthcare). Proteins were expressed by induction with 1 
mM isopropyl β-D-1-thiogalactopyranoside (IPTG) at 25 °C overnight. 
The cells were harvested by centrifugation at 4200 rpm at 4 °C in a J6-MI centrifuge 
(Beckman Coulter) for 30 minutes and resuspended in His-binding buffer (50 mM Tris-Cl, 
pH 7.2, 0.5 M NaCl, 20 mM Imidazole) supplemented with a protease inhibitor cocktail tablet 
and 2 µL of benzonase nuclease (Novagen) before sonication on ice with a Misonix sonicator 
3000 (Qsonica, LLC). The lysate was clarified by centrifugation at 19000 rpm in an SS-34 
rotor in a RC 5C Plus centrifuge (Sorvall) at 4 °C followed by filtration through Minisart 
syringe filters (Sartorius stedim biotech) to prepare it for purification. 
Each protein was purified using a 3-step chromatography purification protocol on the 
ÄKTAxpress system (GE Healthcare). The protocol included (1) His-tagged purification 
through a 5 ml HisTrap FF column (GE Healthcare) with on-column cleavage of the N-
terminal His-tag with human rhino-virus 3C protease (prepared in-house) followed by (2) 
desalting through a HiPrep 26/10 desalting column (GE Healthcare) into anion-exchange 
(AIEX) binding buffer (20 mM Tris-Cl, pH 8.0, 1 mM EGTA) before (3) anion-exchange 
chromatography through a 6 ml Resource Q column (GE Healthcare). The purified fractions 
eluted with AIEX-elution buffer (20 mM Tris-Cl, pH 8.0, 1 M NaCl, 1 mM EGTA) were 
analyzed by SDS-PAGE (details in Section 2.2.3) and then pooled and concentrated by 
centrifugation in Centriprep YM-30 concentrators (Millipore) before size-exclusion 
chromatography through a HiLoad 16/60 Superdex 200 prep grade column (GE Healthcare) 
in buffer containing 5 mM HEPES, pH 7.5, 50 mM NaCl, 0.1 mM EGTA. The purified 
proteins were concentrated and frozen for storage at -80 °C. 
 
2.2.2.2 Gelsolin G2-G3  
The G2-G3 construct was transformed into E. coli Bl21 Star (DE3) cells (Stratagene) 
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for expression according to the manufacturer’s protocol. The cells were grown in Terrific 
Broth (Novagen)-based autoinduction media (25 mM for Na2HPO4 and KH2PO4, 50 mM for 
NH4Cl, 5 mM for Na2SO4, 0.015% (w/v) for D-glucose, 0.6% (w/v) for alpha-lactose, 1.2% 
(w/v) for glycerol, and 2 mM for MgSO4, prepared in-house) (Studier, 2005) at 25 °C 
overnight in a Certomat BS-1 shaker incubator (Sartorius). The cells harvesting, lysis, and 
lysate clarification were completed as described in Section 2.2.2.1.  
G2-G3 was purified using a 3-step chromatography purification protocol on the 
ÄKTAxpress system (GE Healthcare). The protocol included (1) His-tagged purification with 
on-column cleavage, as described, followed by (2) desalting through a HiPrep 26/10 desalting 
column (GE Healthcare) into cation-exchange (CIEX) binding buffer (20 mM MES, pH 6.0, 1 
mM CaCl2) before (3) cation-exchange chromatography through a 6 ml Resource S column 
(GE Healthcare). The purified fractions eluted with CIEX elution buffer (20 mM MES, pH 
6.0, 1 M NaCl, 1 mM CaCl2) were analyzed by SDS-PAGE (details in Section 2.2.3) and then 
pooled and concentrated before size-exclusion chromatography through a HiLoad 16/60 
Superdex 75 prep grade column (GE Healthcare) into buffer containing 50 mM Tris-Cl, pH 
7.5, 50 mM NaCl, 1 mM CaCl2. The purified proteins were concentrated and frozen for 
storage at -80 °C. 
 
2.2.3 Analysis of protein purity  
Protein purity was assessed using sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) as described in standard protocols (Sambrook and Russel, 1989) 
using the Mini-Protean III electrophoresis system (Bio-Rad) in Tris-glycine buffer (25 mM 
Tris, 250 mM glycine, 0.1% SDS). Protein samples were prepared by mixing with 5X 
modified Laemmli buffer (0.225M Tris-Cl, pH 6.8, 50% glycerol, 5% SDS, 0.05% 
bromophenol blue and 0.25 M dithiothreitol (DTT)) and subsequent denaturing by heating at 
95 °C for 5 minutes. After electrophoresis, the gel was stained in coomasie brilliant blue dye 
(0.025% (w/v) coomassie brilliant blue R250, 40% (v/v) methanol, 7% (v/v) acetic acid) for 
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10 min before being destained in water. Pictures of the gel were taken with the Geneflash 
imager (Syngene). 
 
2.2.4 Dynamic light scattering 
The monodispersity of G2-G3 in calcium or EGTA was estimated by dynamic light 
scattering experiments using a Dynapro plate reader (Wyatt Technologies) with 384-well 
plates (Greiner Bio-One). G2-G3, 2 mg/ml, was dialyzed overnight into buffer E (5 mM 
HEPES, pH 7.5, 50 mM NaCl, 0.1 mM EGTA) or buffer C (5 mM HEPES, pH 7.5, 50 mM 
NaCl, 1 mM CaCl2). 50 µL of each sample was added to consecutive wells on the plate and 
the readings taken at 25 ºC to determine polydispersity of the samples.  
 
2.2.5 Functional assays 
The various functions of the gelsolin family proteins were assessed through pyrene-
actin fluorescence based assays. Pyrene-actin is G-actin that has been conjugated with N-(1-
pyrenyl)iodoacetamide at Cys-374. Polymerization of pyrene-labeled G-actin results in 
significantly enhanced fluorescence at 407 nm after excitation at 365 nm (Kouyama and 
Mihashi, 1981). Pyrene-actin copolymerizes with native actin and has identical kinetics 
(Cooper et al., 1983b). However, in functional assays, the preferred range for pyrene doping 
is 1-10% because some actin-binding proteins do not bind pyrene-actin as tightly as native 
actin. Actin-binding proteins, when added to actin, alter the polymerization kinetics and this 
variation can be used to assess their functions. All the assays described within Section 2.2.5 
are pyrene-actin assays where fluorescence is measured at 407 nm with a Safire2 fluorimeter 
(TECAN) after excitation at 365 nm. 
 
2.2.5.1 Actin depolymerization assay 
Buffer F (final concentration, 50 mM KCl, 0.2 mM ATP, 2 mM MgCl2, 0.5 mM 
DTT, 1 mM EGTA, and 50 mM HEPES, pH 7.5) was added to 10% pyrene-labeled G-actin 
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(12 µM or 4 µM) in 96-well, flat-bottomed plates (Corning, NUNC) and incubated for 30 min 
to allow complete polymerization of actin. To obtain the required free calcium concentrations, 
calcium stock solution was then added in amounts calculated using WEMAXCLITE version 
1.15 (http://www.stanford.edu/~cpatton/webmaxc/webmaxclite115.htm). The mixture was 
equilibrated for 1 h before addition of the proteins of interest to make up the total volume in 
each well to 100 µL, and measurement of fluorescence intensity.  
 
Comparing the effect of calcium-binding mutations on gelsolin activity 
The actin-depolymerization activity of gelsolin and its calcium-binding site mutants 
was analyzed in EGTA and at 10 µM free calcium. In the case of the experiments conducted 
in EGTA, de-ionized water was added to pyrene-labeled F-actin, instead of calcium stock 
solution. The proteins of interest (gelsolin, tail-less gelsolin and various mutants) were added 
in a molar ratio of 1:2 to F-actin before measuring fluorescence intensity in real-time. The 
change in fluorescence intensity after addition of the protein of interest was plotted as a 
function of time to compare the activities of various mutants.  
 
Determination of calcium concentration required for activation 
 To determine the free calcium concentration necessary to activate full-length gelsolin, 
full-length adseverin and the N- and C-terminal halves of adseverin, a free calcium gradient 
was prepared by adding the requisite amounts of calcium stock solution as calculated using 
WEBMAXCLITE version 1.15. After equilibration for 1 h, the proteins of interest were added 
at a molar ratio of 1:2 (full-length gelsolin and full-length adseverin) or 1:1 (N- and C-
terminal halves of adseverin) to F-actin. The mixture was allowed to equilibrate and 
fluorescence intensity was measured at various time points until reactions reached steady 
state, at which point readings were stable across the calcium concentration range. The steady 
state fluorescence intensity was plotted as a function of free-calcium concentration to 
determine the amount of calcium necessary for activating the proteins. 
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2.2.5.2 Actin monomer sequestration assay 
10% pyrene-labeled G-actin (6 µM or 4 µM) was incubated with the respective 
proteins in a 2:1 (full-length proteins of the gelsolin family – gelsolin, adseverin, scinderin-
like A and scinderin-like B) or 1:1 (fragments of gelsolin and adseverin) molar ratio for 30 
min in buffer A (2 mM Tris-HCl, pH 7.2, 0.2 mM ATP, 0.5 mM DTT, 0.2 mM CaCl2) in a 
final volume of 90 µL in 96-well flat-bottomed plates. 10 µL of polymerization buffer, 10 Χ 
KM (1 M KCl, 20 mM MgCl2), was added to each reaction before measuring fluorescence 
intensity kinetically using a Safire2 fluorimeter. 
 
Monomer sequestration by gelsolin calcium-binding site mutants 
 To assess the ability of the various mutants of gelsolin to sequester actin monomers in 
the absence of calcium, the proteins were incubated at a molar ratio of 1:2 with 10% pyrene-
labeled G-actin in modified buffer A (2 mM Tris-HCl, pH 7.2, 0.2 mM ATP, 0.5 mM DTT) 
for 15 min. The G-actin used had been pre-dialyzed in modified buffer A for 6 h. 
Polymerization was induced by the addition of 10 µL of polymerization buffer, 10 Χ KMEI 
(50 mM KCl, 1 mM MgCl2, 1 mM EGTA, 10 mM imidazole-HCl, pH 7.5), before kinetic 
measurement of fluorescence intensity. A second experiment was conducted where the 
incubation period was extended to 45 min while all other steps in the protocol were 
unchanged. 
 
2.2.5.3 Actin filament nucleation assay 
10% pyrene-labeled G-actin (6 µM or 4 µM) was incubated for 10 min with the 
respective protein at a molar ratio of 1:100 in buffer A in a final volume of 90 µL in 96-well 
flat-bottomed plates. 10 µL of 10 Χ KM was added to each reaction before kinetic 
measurement of fluorescence intensity. 
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Nucleation by gelsolin calcium-binding site mutants 
The proteins of interest were incubated at a molar ratio of 1:100 with pre-dialyzed 
pyrene-labeled actin in modified buffer A (2 mM Tris-HCl, pH 7.2, 0.2 mM ATP, 0.5 mM 
DTT) before polymerization was induced by the addition of 10 µL of 10 Χ KMEI and 
fluorescence intensity measured kinetically. 
  
2.2.6 Preparation of protein complexes 
His-tag purified scinlA and scinB were added to F-actin at a molar ratio of 1:2.5 and 
incubated on ice for 10 minutes to allow scinlA and scinlB to completely sever F-actin and 
form complexes. The scinlA and scinlB complexes were then purified by size exclusion 
chromatography through a HiLoad 16/60 Superdex 200 column (GE Healthcare) in modified 
F-buffer (50 mM HEPES, pH 7.5, 50 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 0.2 mM ATP, 0.5 
mM DTT).  Calcium was added to the standard F-buffer recipe in order to ensure that scinlA 
and scinlB remain active and bound to actin. 
 
2.2.7 Crystallization 
Initial crystallization screening was performed using the sitting-drop vapor-diffusion 
method. The Screenmaker 96+8 Xtal (Innovadyne Technologies) was used to set up trial 
experiments in two-drop, 96-well Innovaplate SD-2 (Innovadyne Technologies) with various 
screens in deep well block format (Hampton Research, Emerald Biosystems, Qiagen). The 
PCT pre-crystallization test (Hampton Research) was used to determine appropriate 
concentration of protein for crystallization setup. For each condition, 200 nL of protein 
solution was mixed with 200 nL of reservoir solution and equilibrated against 50 µL of 
reservoir solution in the well. Plates were prepared in duplicate, sealed with VIEWseal 
transparent adhesive sealers (Greiner Bio-One), and incubated at 15 °C and 25 °C.  
Crystallization optimization experiments were set up using the hanging-drop vapor-
diffusion method (McPherson, 1982), in pre-greased VDX-48 plates (Hampton Research) 
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with 12 mm siliconized circle cover slides (Hampton Research). 1 µL of protein was mixed 
with 1 µL of reservoir solution and equilibrated against 250 µL of reservoir solution in the 
well. Optimization strategy used was as described by Zeelen (1999). Protein and precipitant 
concentrations, pH and temperature were varied during optimization to identify ideal 
crystallization conditions.   
 
2.2.8 Data collection 
Crystals were transferred to appropriate cryo-protection solutions before being picked 
up in Cryoloops (Hampton Research) and flash frozen in liquid nitrogen for subsequent data 
collection. X-ray diffraction data were collected on beamline BL13B1 on the Area Detection 
Systems Corporation Quantum 315 CCD detector at the National Synchrotron Radiation 
Research Center (NSRRC), Taiwan. The wavelength was set to 1 Å and the data collected at 
105 K. Datasets were indexed, scaled and merged in HKL2000 (Otwinowski and Minor, 
1997). 
 
2.2.9 Structure solution, refinement and analysis 
 All three structures presented in this work were solved by molecular replacement. 
Specific programs used for each structure are described below. The geometry of the structures 
solved was checked with PROCHECK (Laskowski et al., 1993). Structures were compared 
with SUPERPOSE (Krissinel and Henrick, 2004). 
 
2.2.9.1 Human G1-G3/actin complex 
The structure of G1-G3/actin was solved with programs, MOLREP (Vagin and 
Teplyakov, 1997), REFMAC5 (Murshudov et al., 1997) and COOT (Emsley and Cowton, 
2004) from the CCP4 suite of crystallographic programs (1994). The initial structural solution 
of G1-G3/actin was determined by molecular replacement in MOLREP using the equine G1-
G3/actin structure (PDB ID 1RGI, Burtnick et al., 2004) as the template. Several cycles of 
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manual rebuilding with COOT and reciprocal space refinement with REFMAC5 including 
restrained refinement and TLS refinement while maintaining strict noncrystallographic 
restraints yielded the final structure of G1-G3/actin.  
 
2.2.9.2 Calcium-bound human G3 
The structure of calcium-bound G3 was solved with ARP/wARP (Langer et al., 
2008), REFMAC5 and COOT from the CCP4 suite. Initial attempts to obtain a molecular 
replacement solution in MOLREP using G2G3 from the human G1-G3/actin structure as the 
template failed. Subsequently, the individual domains G2 and G3 from human G1-G3/actin 
were used as templates. Initial solution obtained with G2 as a template had an R-factor of 
60.0% and a correlation coefficient of 0.484, while that obtained with G3 as a template had an 
R-factor of 54.7% and a correlation coefficient of 0.586. The G2 solution could not be refined 
beyond R-factor 46.7% whereas G3 refined to 30.8%. G3 was therefore selected as the 
template for automated model building in ARP/wARP. Thereafter, a few cycles of manual 
rebuilding with COOT and reciprocal space refinement with REFMAC5 resulted in the final 
structure of calcium-bound G3. 
 
2.2.9.3 Zebrafish scinderin-like B 
The structure of scinderin-like B (scinlB) was solved with PHASER (McCoy et al., 
2007), COOT, and REFMAC5 from the CCP4 suite and phenix.refine from the PHENIX 
software suite (Adams et al., 2010). Attempts to obtain an initial molecular replacement 
solution with human calcium-free gelsolin (PDB ID 3FFN), G1-G3 from human G1-G3/actin 
(PDB ID 3FFK) or human G4-G6 (PDB ID 1P8X) as templates in MOLREP failed. The 
individual domains from calcium-free human gelsolin were then used for maximum-
likelihood molecular replacement in PHASER to obtain the initial structure solution, which 
revealed the presence of one copy of each domain. Multiple cycles of manual building in 
COOT and refinement in REFMAC5 were then used to improve the model of scinlB. 
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Automated refinement including rigid body refinement, energy minimization, simulated 
annealing, water-picking and B-factor refinement in PHENIX resulted in the final structure. 
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Chapter 3. Calcium activation of gelsolin – Part I 
[Some of the work presented in this chapter has been published (Nag et al., 2009). The 
abstract of the publication is enclosed in the Appendices.] 
 
3.1 Background   
While gelsolin function is regulated by several factors, by all accounts calcium is the 
primary activator. Calcium binding activates gelsolin by inducing large conformational 
changes in a reversible manner (Ashish et al., 2007; Chumnarnsilpa et al., 2006). Gelsolin has 
eight conserved calcium-binding sites, determined from sequence and structure analysis, that 
are classified as type-I and type-II (Burtnick et al., 2004; Choe et al., 2002; Kazmirski et al., 
2002).  Residues from both gelsolin and actin coordinate calcium ions bound to the two type-I 
sites that are located in G1 and G4. In contrast, only the conserved residues of gelsolin 
coordinate the calcium ions bound to the six type-II sites, one in each domain. The type-I sites 
have been implicated in stabilizing the gelsolin-actin interactions, while the type-II sites are 
believed to participate in the calcium-mediated conformational changes and maintenance of 
structural integrity of gelsolin.  
Gelsolin activity is known to vary with calcium concentration although there are 
conflicting reports about the exact concentrations. In the absence of calcium, gelsolin is 
completely inactive and does not interact with actin. In low calcium below 1.5 µM, gelsolin is 
partially activated and functions as a filament-capping protein but severs and nucleates 
filaments with low efficiency (Allen and Janmey, 1994; Gremm and Wegner, 2000; Kinosian 
et al., 1998). At intermediate calcium levels (~ 0.2 – 20 µM), which are likely to be 
predominant in the cytoplasm, the presence of actin may result in the sequestration of non-
equilibrium calcium and permit severing to occur (Allen and Janmey, 1994; Kinosian et al., 
1998; Weeds et al., 1995). At high calcium levels (> 0.5 mM) as in the blood plasma, gelsolin 
achieves maximal activation and is a fully competent capping, severing and nucleating protein 
(Kinosian et al., 1996). The underlying mechanism for the precise control of these functions 
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is the concealment or exposure of the appropriate actin-binding sites in response to inhibitors 
or activators, respectively.  
To completely elucidate the structural mechanisms through which calcium activates 
gelsolin, one would have to observe the molecule dynamically undergoing the various 
conformational changes. This being technologically unfeasible, efforts have been made to 
obtain snapshots of gelsolin in various conformations. However, this approach has also been 
limited by the inherently dynamic nature of the protein. Moreover, the propensity of gelsolin 
to get cleaved into its halves, 10-fold faster in the presence of calcium than in EGTA (Bryan 
and Hwo, 1986), has precluded the crystallization of the whole molecule in any calcium-
bound state. The current understanding of the structural mechanisms involved in the calcium-
activation of gelsolin is therefore, drawn from the coalescence of data gleaned from the high 
resolution X-ray crystal structures of inactive equine and human gelsolin, active calcium-
bound human and mouse G4-G6, active human G4-G6/actin, and calcium-bound equine G1-
G3/actin and low resolution biophysical and structural analyses like dynamic light scattering, 
radiolytic footprinting and small angle X-ray scattering (SAXS) modeling.  
The calcium-dependent changes in gelsolin conformation are responsible for, and 
occur concurrently with, the changes in gelsolin function. With increase in calcium 
concentration, the radius of gyration and maximum linear dimension of gelsolin increase by 
50% (Ashish et al., 2007). Studies through methods such as dynamic light scattering, 
radiolytic footprinting and SAXS modeling have identified two distinct transitions that occur 
at ~ 0.1 to ~ 5 µM and ~ 10 µM to ~ 1 mM (Ashish et al., 2007; Kiselar et al., 2003a, b; 
Patkowski et al., 1990; Pope et al., 1997). These transitions separate the conformations of 
gelsolin into three identifiable groups implying that discrete calcium-binding events have 
distinct effects on gelsolin conformation (Ashish et al., 2007).  
In the presence of EGTA, gelsolin is inactive and has a compact globular 
conformation that is detailed by high-resolution crystal structures and corroborated by the low 
resolution SAXS envelope (Ashish et al., 2007; Burtnick et al., 1997; Nag et al., 2009). 
However, in the more physiologically relevant environment without calcium chelators such as 
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EGTA, gelsolin has a slightly expanded, but still globular structure. The difference between 
the conformations of gelsolin with and without EGTA are detectable by light scattering and 
SAXS but not radiolytic footprinting, indicating that these variations represent an overall 
expansion of molecular dimensions instead of conformational changes that would alter the 
solvent accessibility of specific residues (Ashish et al., 2007; Kiselar et al., 2003a, b; Pope et 
al., 1997). One can thus surmise that the characteristics of the inactive conformation of 
gelsolin, detailed by the crystal structures of inactive equine plasma and human cytoplasmic 
gelsolins (Section 1.4.3.1; Fig. 1.10), hold true at very low calcium concentrations. 
Various studies have provided evidence that the activation of gelsolin is dependent on 
the structural reorganization of the C-terminal half  of the protein that involves the release of 
the C-terminal tail and G4-G6 latches, and results in the exposure of the actin-binding sites on 
G2, G4 and G6 (Choe et al., 2002; Kolappan et al., 2003; Narayan et al., 2003a; Robinson et 
al., 1999). These calcium-induced changes in G4-G6 are a prerequisite for the binding of 
actin and for maintaining the stability of the G4-G6/actin complex (Khaitlina et al., 2004; 
Pope et al., 1995). Intriguingly then, especially when one considers that the two halves of 
gelsolin are sufficiently similar to suggest that they have arisen from a gene duplication event, 
the N-terminal half of gelsolin (G1-G3) severs actin filaments in a calcium-independent 
manner when isolated from G4-G6, although the efficiency of function remains calcium-
sensitive (Allen and Janmey, 1994; Bryan and Hwo, 1986; Hellweg et al., 1993; Kwiatkowski 
and Yin, 1987; Selden et al., 1998). The structural reorganization of G4-G6 is thus 
responsible, not only for its own activation, but also for the removal of structural constraints 
that keep G1-G3 inactive. However, the mechanism through which calcium binding to G4-G6 
is translated into the activation of G1-G3 is poorly understood. The mechanism that permits 
G1-G3 to function in a calcium-independent manner, in the absence of G4-G6, also remains 
unknown. 
The structures of gelsolin determined so far, reveal that when gelsolin is fully 
activated and bound to actin, at least seven of the eight calcium-binding sites are occupied 
(Burtnick et al., 2004; Choe et al., 2002). The calcium-binding site of G2 is vacant in the 
Chapter 3. Calcium activation of gelsolin – Part I 
 48 
structure of calcium-bound equine G1-G3/actin. This is in contradiction with studies that 
establish the ability of G2 to bind calcium with high affinity (Kd=0.7 µM, Chen et al., 2001; 
Kd=0.1 µM, Roustan et al., 2007). In order to reconcile this conflict it was proposed that 
calcium-binding at the G2 site is transient.    
In order to gain a clearer picture of the structural mechanisms responsible for the 
activation and function of G1-G3, structural and functional analyses of the N-terminal half of 
recombinant human cytoplasmic gelsolin were undertaken. The structures of the activated G1-
G3 in complex with actin and isolated calcium-bound G3 were determined. These structures 
and their analyses are presented here.  
 
3.2 Results 
3.2.1 3 Å structure of the N-terminal half of human gelsolin in complex with actin  
G1-G3/actin crystallized in the P212121 spacegroup and there were two molecules in 
the asymmetric unit. The structure of G1-G3/actin was solved by molecular replacement with 
equine G1-G3/actin structure as the template (Chapter 2, Section 2.2.8.1). The data collection, 
crystal and refinement statistics are presented in Table 3.1. 
 
3.2.1.1 Description of the human G1-G3/actin structure 
The structure of recombinant calcium-bound N-terminal half (G1-G3) of human 
cytoplasmic gelsolin in complex with rabbit skeletal actin was solved at 3 Å (Fig. 3.1B). 
Large-scale rearrangements, analogous to those displayed by the equine gelsolin (Burtnick et 
al., 2004), have disrupted the interactions of G1 with both G2 and G3 that are evident in the 
inactive conformation (Fig. 3.1A). The G1 C′ and G2 A′ strands that form a small continuous 
sheet between G1 and G2, in the inactive state, separate during activation so that the G1 C′ 
strand remains bound to G1 while the G2 A′ strand forms part of the extended G1-G2 linker. 
G1 is bound to actin through the long helix at the previously determined site between 
subdomains 1 and 3 (McLaughlin et al., 1993). 





Table 3.1. Statistics for G1-G3/actin 
 
Statistics Active human G1-G3/actin 
Wavelength, Å 1  
Space group P212121 
a, Å 102.2 
b, Å 146.9 
c, Å 148.3 
α, ° 90 
β, ° 90 
γ, ° 90 
Resolution range, Å 30.0 – 3.0 (3.1 – 3.0) 
Unique reflections 42,953 (3,119) 
Completeness, % 99.7 (99.9) 
Average I/Io 19.2 (5.7) 
Rmerge, % 8.8 (28.2) 
Rfactor, % 20.1 (27.3) 
Rfree, % 27.3 (33.8) 
Molecules in the asymmetric unit 2 
Gelsolin residue range Mol 1: 28-374; Mol 2: 27-372 
Actin residue range Mol 1: 3-47, 49-368; Mol 2: 5-38, 50-370 
Non-hydrogen atoms (waters) 11,687 (473) 
Mean derived B-factor (waters), Å2 31.2 (31.1) 
rmsd bonds, Å 0.009 
rmsd angles, ° 1.26 
 



















The G1-G2 linker is extended across the face of actin so that G2 interacts with actin 
subdomain 2. The G2-G3 linker that is extended in the inactive conformation, has condensed 
into a helix, thus bringing G2 and G3 together and creating a new interface. This positions G3 
such that it forms interactions with actin subdomain 1. Surprisingly, all the calcium-binding 
sites in the structure are occupied, including the G2 type-II calcium-binding site, which has 
not previously been structurally observed bound to a calcium ion. The other calcium ions are 
located within the type-I site in G1, type-II sites in G1 and G3 and the cation-binding site in 
Figure 3.1. Comparison of human and equine G1-G3/actin structures. (A) Structure of 
inactive human G1-G3 displayed so that G2 is in a similar orientation to B. The G2 A′ and 
G1 C′ strands are labeled. (B) Structure of the activated human gelsolin N-terminal half in 
complex with calcium. There are 5 bound calcium ions depicted as black spheres. The 
arrow indicated the furin cleavage site between residues 172 and 173. The G2 A′ and G1 
C′ strands that are repositioned during activation and are labeled. (C) Domains 2 and 3 of 
human cytoplasmic gelsolin. (D) Domains 2 and 3 of equine plasma gelsolin. Calcium-
binding residues are displayed in both B and C. Adapted from Nag et al., 2009. 
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the actin inter-domain cleft. Intriguingly, the Cys-188 – Cys-201 disulfide bond is present in 
G2. 
3.2.1.2 Comparison with the structure of calcium-bound equine G1-G3/actin 
The structures of the activated N-terminal halves of human cytoplasmic and equine 
plasma gelsolin were compared to determine if there are any significant differences. The two 
structures are nearly identical, as can be expected from the high sequence homology. 
However, there are three mentionable differences, all of which are localized within G2 (Figs. 
3.1C and 3.1D). First, the G2 type-II calcium-binding site, which is vacant in the equine 
structure, is occupied by a calcium ion in the human G1-G3/actin structure. Secondly, Cys-
188 and Cys-201 form a disulfide bridge in G2 of the human gelsolin structure. Finally, when 
the G2 calcium-binding site is inspected closely, it is evident that Asp-259, which in the 
equine gelsolin structure interacts with the G2-G3 linker, is repositioned so that it completes 
the G2 calcium-coordination sphere with Asp-187 and Glu-209.  
 
3.2.1.3 Comparison with the structure of cadmium-bound G2 
The presence of a calcium-ion in the G2 type-II site of the human G1-G3/actin 
structure, previously believed to only bind calcium transiently, prompted the comparison of 
G2 from this structure with the cadmium-bound structure of isolated human G2 (Kazmirski et 
al., 2002). Superimposition reveals that the same residues are involved in cation coordination 
in both structures, although variation in the coordination sphere is observed (Fig. 3.2D). 
Cadmium displays five bonds, two each with Glu-209 and Asp-259 and one with Asp-187, 
whereas calcium exhibits four bonds, two with Glu-209 and one each with Asp-187, Asp-259. 
The Cys-188 – Cys-201 disulfide-bridge is present in both structures. However, cadmium-G2 
also coordinates two extra cadmium ions at residues Glu-175 and Glu-258, with the 
corresponding residues from adjacent molecules within the crystal lattice (Figs. 3.2A and 
3.2B). Variations between the two structures are located in the loop N-terminal to the G2-G3 
linker, the AB loop, and the G2 B strand, which in G1-G3/actin are juxtaposed with G3 (Fig. 
3.2C). In particular, Arg-172 is repositioned in G1-G3/actin to avoid clashes with the G2-G3 
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linker suggesting that the minor variations that are observed between the two structures of G2 
are due to the adjustments in calcium-bound G2 that are necessary to form the G2-G3 










Figure 3.2. Comparison of Ca2+- and Cd2+-bound structures of G2 (A) Structure of Ca2+-
bound G2 from the G1-G3/actin structure. (B) Structure of Cd2+-bound G2 (Kazmirski et al., 
2002). The three Cd2+ ions (wheat) stabilize the crystal contacts. (C) Differences between 
Ca2+- and Cd2+-bound G2 are localized near the G2-G3 linker and AB loop (encircled in red), 
and strand B (labeled). Of particular note is Arg-172 (dark grey), which in the Cd2+-bound 
conformation would clash with the G2-G3 linker. (D) and (E) Cation-coordination spheres of 
Ca2+-bound and Cd2+-bound G2, respectively. Residues from Ca2+-bound G2 are displayed in 
light grey and those from Cd2+-bound G2 are displayed in dark grey. 
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3.2.2 1.2 Å structure of activated G3 in isolation  
3.2.2.1 Preparation and characterization of G2-G3 
A construct consisting of gelsolin domains 2 and 3 (residues 130-374) was prepared. 
The expressed and purified protein, G2-G3, ran as a single peak during gel filtration and was 
found to be mono-disperse in the presence of calcium (% Pd = 6.4), when examined by 
dynamic light scattering (Figs. 3.3A, 3.3B and 3.3C). In EGTA, G2-G3 is monomodal but 
polydisperse (% Pd = 30.5) suggesting that a range of conformations may be present in 
solution, in the absence of calcium (Fig. 3.3D). G2-G3, at 40 mg/ml in 50 mM Tris-Cl, pH 
7.5, 150 mM NaCl, 1 mM CaCl2, was set up for crystallization. G2-G3 itself, has proven 
recalcitrant to crystallization and no crystals of this fragment have been obtained as yet. Auto-
cleavage within the crystal drop resulted in the formation of a G3 crystal in 10% (v/v) 








Figure 3.3. G3 – from protein to crystal. (A) Chromatogram for the size-exclusion 
chromatography of G2-G3. (B) SDS-PAGE. Lane 1 - Broad range marker (Bio-Rad); Lane 2 
- Purified G2-G3 protein (26 kDa). (C) and (D) Dynamic light scattering shows that G2-G3 
is monomodal monodisperse in the presence of calcium, but polydisperse in EGTA. (E) and 
(F) G3 crystal viewed in through polarizing and UV filters, respectively. 
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3.2.2.2 Data collection, modeling and refinement of G3 
The G3 crystal was cut into small pieces and soaked in precipitant solution 
supplemented with 15% glycerol before being picked up in nylon cryoloops (Hampton 
Research) and flash frozen in liquid nitrogen for subsequent data collection. G3 crystallized in 
the C2 spacegroup and there were two molecules in the asymmetric unit. The structure was 
solved by molecular replacement with the structure of G3 from human G1-G3/actin as the 
template (Chapter 2, Section 2.2.8.2). The data collection, crystal and refinement statistics are 
presented in Table 3.2.  
 
3.2.2.3 The structure of active gelsolin domain 3 in isolation 
Isolated calcium-bound G3 folds into the typical gelsolin domain structure with a 
five-stranded β-sheet sandwiched between two helices, one long helix parallel and a short one 
perpendicular to the sheet (Fig. 3.4A).  The long helix of G3 is straight and the type-II 
calcium-binding site is occupied by a calcium ion that is coordinated by the backbone oxygen 









Figure 3.4. Structure of isolated calcium-bound G3. (A) Schematic representation of 
calcium-bound G3. The calcium ion is depicted as a grey sphere. (B) The calcium 
coordination site of G3. Three water molecules (light blue spheres) complete the coordination 
sphere with Glu-327, Asp-303 and the backbone oxygen of Glu-302. (C) Electrostatic 
interactions between Asn-278 from the AB loop and Asn-324 from the loop N-terminal to the 
long helix, and hydrogen bonds formed by various residues with the calcium-coordinating 
waters stabilize this conformation. 






Table 3.2. Data collection and refinement statistics for calcium-bound G3 
Statistics Active G3 
Wavelength, Å 1  
Space group C2 
a, Å 58.3 
b, Å 41.8 
c, Å 84.8 
α, ° 90 
β, ° 105.3 
γ, ° 90 
Resolution range, Å 50.0 – 1.2 (1.3 – 1.2) 
Unique reflections 51736 (5137) 
Completeness, % 99.3 (99.3) 
Average I/Io 25.95 (3.29) 
Rmerge, % 4.0 (28.2) 
Rfactor, % 17.4 (25.6) 
Rfree, % 19.6 (26.9) 
Molecules in the asymmetric unit 2 
Gelsolin residue range 270 - 371 
Non-hydrogen atoms (waters) 1927 (272) 
Mean derived B-factor (waters), Å2 7.3 (17.1) 
rmsd bonds, Å 0.012 
rmsd angles, ° 1.42 
 





Chapter 3. Calcium activation of gelsolin – Part I 
 56 
(residue 303) and glutamate (residue 327) (Fig. 3.4B). Several hydrogen bonds between the 
calcium-coordinating water molecules and residues from the adjacent loops stabilize this 
conformation. Furthermore, electrostatic interactions between Asn-278, from the AB loop, 
and Asn-324, from the loop N-terminal to the long helix, maintain the straight and parallel 
conformations of the long helix and the A and B strands (Fig. 3.4C). 
 
3.2.2.4 Comparison with active G3 from the G1-G3/actin structure 
The structure of isolated calcium-bound G3 was compared with that of G3 from the 
structure of G1-G3/actin in order to determine the influence of other domains or actin on the 










Figure 3.5. Comparison of isolated active G3 with active G3 from the G1-G3/actin structure. 
(A) Structure of active G3 (brown) is superimposed on the corresponding domain of G1-
G3/actin (yellow). Calcium is displayed as a grey sphere. Regions of variation are encircled 
in blue. (B) The interfaces with G2 (green) and actin (pink) are shown. Residues from G2 
and actin that interact with G3 are labeled. (C) G1-G3/actin structure with the surface charge 
distribution of G3 displayed. The negatively charged residues from G2 and actin interact 
with the positively charged patches (blue) on G3. (D) The surface charge distribution of the 
three structures of G3 is compared. Changes at the two ends of the long helix are encircled in 
light green and those at strand E in dark green. 
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While the overall fold is identical in both structures, there are minor differences localized 
mainly in three regions, namely, the AB loop (loop between the A and B strands), the LhCt 
loop (loop between long helix and the E strand), and the short helix (Fig. 3.5A). The short 
helix of G3 in the G1-G3/actin structure lies at the interface with G2 and displays a small 
displacement, compared to isolated active G3 (Fig. 3.5B), that corresponds to the shift in the 
G2 B strand within the same structure (Fig. 3.2C). Examination of the surface charge 
distribution of G3 within the G1-G3/actin structure (Fig. 5.3C) displays positively charged 
patches (blue) located ideally to interact with negatively charged residues from G2 (Gln-224) 
and actin (Gln-4 and Gln-100). Comparison of the surface charge distribution of isolated 
calcium-bound G3, G3 from the G1-G3/actin structure and inactive G3 from the human 
calcium-free gelsolin structure, reveals changes introduced by the straightening of the long 
helix and AB loop (Fig. 3.5D).  
 
3.2.2.5 Comparison with inactive G3 
The active and the inactive conformations of G3 differ primarily in the regions 
surrounding the calcium-binding site, which is only occupied in the active conformation, and 
the LhCt loop (Fig. 3.6A). As opposed to the active conformation, where the long helix and 
the A and B strands are straight and parallel, the inactive conformation exhibits a bent helix. 
The A and B strands are bent towards the helix, so that the AB loop appears to interact with, 
and cause the bend in, the long helix.    
In the inactive conformation of gelsolin, the β-strands of G1 and G3 are aligned to 
form a continuous β-sheet that stabilizes this conformation (Fig. 3.6B). Superimposition of 
the structure of isolated G3 on inactive gelsolin reveals that calcium binding induces 
conformational changes that result in clashes between the antiparallel E strands of G1 and G3. 
In particular, Gln-347 and Gln-349 of G3 clash with Phe-125 and Arg-120 of G1, respectively 
(Fig. 3.6C). Interestingly, G3 from the G1-G3/actin structure displays additional clashes with 
Val-122 of G1, as compared to isolated active G3 (Fig. 3.6D). 

















Figure 3.6. Role of G3 activation in releasing the G1-G3 latch. (A) The structure of active 
isolated G3 (wheat) is superimposed on the inactive G3 (yellow) Calcium is depicted as a 
grey sphere. Most of the differences between the two structures are located in the vicinity of 
the calcium-binding site. (B) The G1-G3 latch in calcium-free gelsolin. Surface 
representation of G3 (yellow) shows no clashes with G1. (C) Surface representation of 
isolated Ca2+-bound G3 superimposed on calcium-free gelsolin. Clashes with the E strand 
of G1 are apparent. A closer look at the region displays the specific residues involved. (D) 
Surface representation of G3 from G1-G3/actin displays additional clashes with the E strand 
of G1 as compared with isolated G3. A closer look at the region identifies the residues 
involved. The long helix of G1 has been removed from the representations in B, C, and D 
for clarity. B, C and D are displayed in the same orientation. 
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3.3 Discussion 
Domain 2 plays a vital role in the activation of gelsolin 
 When compared with the structure of equine G1-G3/actin, the human structure shows 
the greatest variation in the vicinity of the G2 calcium-binding site. Therefore, this region of 
the inactive human gelsolin structure was examined, to determine the extent of the changes 
that have occurred at this site between the inactive and the active states.  
 Calcium-free human gelsolin displays two discrete, oppositely charged patches when 
the electrostatic surface of the protein is inspected (Fig. 3.7A). The polyphosphate-binding 
site for ATP that is also speculated to bind PIP2 (Urosev et al., 2006) appears as a positive 
patch. The negatively charged patch encompasses the interface between G2 and G6. This 
highly negative junction is created by the complex electrostatic interactions between residues 
from both domains, including those that are part of the unoccupied conserved type-II sites of 
both G2 and G6. Of particular note, are the interactions of Arg-168 and Arg-169 (G2) with 
Asp-669 and Asp-670 (G6 type-II site). In fact, Arg-168 mediates the interaction of Asp-669 
with Asn-206 and Glu-209 (G2 type-II site). The C-terminal tail helix is held in close 
proximity to G2 by interactions of Arg-207 (G2) with Asp-744 and Asp-747 (C-terminal tail). 
The numerous interactions between the residues of the calcium binding sites of G2 and G6 
strongly suggest that calcium will bind these two sites in an interdependent and cooperative 
manner, and disrupt the G2-G6 interface through direct competition. 
From the structure, it appears that the binding of calcium to G2 initiates several 
changes in local structure that may combine to effect the activation of gelsolin. Glu-209 
appears to move closer to Asp-187 to complete the calcium-coordination sphere, and draw 
Asn-206 away from Arg-168, thus breaking the interaction between these two residues and 
resulting in increased mobility of Arg-168 and through proximity, Arg-169 (Fig. 3.7B). 
Consequently, the contacts between G2 and G6 may be weakened. Binding of calcium may 
also be responsible for the slight straightening of the G2 helix thus allowing the interaction of 
Asn-206 with Glu-209. This movement possibly alters the position of Arg-207 and breaks its 
interactions with the tail helix causing the latter’s release. Additionally, Asp-259 completes  











the calcium-coordination sphere and in the process may contribute to the ordering of the G2-
G3 linker, thus creating a steric clash between G2 and G6. Thus, calcium-binding to G2 
possibly participates in the activation of gelsolin by disrupting the G2-G6 interface, altering 
contacts with the C-terminal tail, and creating steric clashes with G6 through the ordering of 
the G2-G3 linker. 
Concurrently with the changes effected within G2 by the binding of calcium, G6 
possibly undergoes conformational changes due to the cooperative binding of a calcium ion. 
Figure 3.7. Cooperative role of G2 and G6 in gelsolin activation (A) Schematic and 
electrostatic surface representations of Ca-free human gelsolin, highlighting the charged 
residues at the G2/G6 interface. (B) Schematic representations of Ca-bound G6 and G2, 
respectively taken from the structures of Ca-bound equine G4-G6/actin (PDB ID 1H1V) 
and human G1-G3/actin, in orientations similar to those presented in A. G2 and G6 have 
been translated relative to their positions in A to avoid steric clashes. Note that the calcium 
ions are coordinated by residues that previously made up the network of interactions 
between G2 and G6 in A. Reproduced from Nag et al., 2009. 
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Asp-669 and Asp-670 form part of the calcium-coordination sphere in preference to the 
interactions with Arg-168 and Arg-169 from G2, thus disrupting the G2-G6 interface (Fig. 
3.7B). The completion of the calcium-coordination sphere by Glu-692 is made possible by the 
straightening of the G6 long helix. Formation of a hydrogen bond between Ser-646 (from the 
G6 AB loop) and Glu-692 may stabilize this conformation. Movement of the AB loop to 
achieve this interaction possibly results in a steric clash with G2 that could push the two 
domains apart.  
Thus, the cooperative binding of calcium to G2 and G6 offers a simple, yet elegant 
mechanism that may contribute to the activation of gelsolin wherein calcium (i) binds to these 
two proximate sites cooperatively, (ii) competes for the residues that maintain the inactive 
conformation and thereby destabilizes it, (iii) induces local conformational changes in G2 that 
aids the opening of the tail-latch and (iv) induces conformational changes in both G2 and G6 
that are incompatible with the compact globular structure and pushes the two halves apart. 
 
Actin-independent activation of the gelsolin N-terminal half  
The cadmium-bound structure of G2 was the first structure of an N-terminal domain 
of gelsolin to be solved in the absence of actin (Kazmirski et al., 2002). However, the 
presence of three non-physiological cations in this structure made a case against its 
physiological relevance. However, the similarities in the structures of active G3, in isolation 
and in the context of the G1-G3/actin complex, suggest that calcium binding can activate G1-
G3 in the absence of actin. Furthermore, in the absence of calcium, G2-G3 exists in a range of 
conformations resulting in polydispersity as measured by dynamic light scattering (Fig. 
3.3D). The monodisperse, monomodal distribution observed for G2-G3 in calcium, indicates 
that calcium binding drives G2-G3 into its stable active conformation (Fig. 3.3C). 
The structures of the activated halves of gelsolin are significantly different. While 
G4-G6 adopts a compact L-shaped structure with G5 serving as a bridge between G4 and G6, 
G1 is separated from G2-G3 by an extended linker in activated G1-G3. Hence, it is evident 
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that the complete activation of G1-G3 requires at least one additional conformational change, 
namely the stretching of the G1-G2 linker.  
Binding of calcium to G3 possibly induces a series of changes in its conformation. 
Glu-327 would be drawn closer to Glu-302 and Asp-303 to form the calcium-coordination 
sphere. This movement may straighten the long helix and create steric clashes that push the 
AB loop away. Asn-278 from the AB loop would then be ideally located to form electrostatic 
interactions with Asn-324 and hydrogen bonds with the calcium-coordinating waters (Figs. 
3.8B and 3.4C). The straightening of the long helix may induce minor adjustments in the 
conformation of the G3 β-sheet in order to form the ideal intra-domain interactions. 
Consequently, the G3 E strand that forms anti-parallel sheet contacts with the G1 E strand 
may be slightly displaced and result in clashes between residues Gln-347 and Gln-349 from 
G3 and residues Phe-125 and Arg-120 of G1 (Fig. 3.6C), which then spring the G1-G3 latch 
and push the two domains apart. Meanwhile, binding of calcium to G2 would induce the 
conformational changes described earlier. The condensation of the G2-G3 linker by calcium 
binding to G2 and breaking the G1-G3 latch by calcium-binding to G3, may cooperate to 
relocate G3 to its new position abutting G2, thus displacing that the G2 A′ and G1 C′ strands 
that occupy this position in the inactive conformation (Figs. 3.1A and 3.1B) and inducing the 
extension of the G1-G2 linker, which may then become competent to bind actin. This model 
for the activation of actin-independent activation of G1-G3 is consistent with the low-
resolution SAXS models of the gelsolin envelope obtained in the presence of calcium, but in 
the absence of actin (Ashish et al., 2007).  
 
Possible mechanism for the calcium-independent activation of the gelsolin N-terminal 
half  
The ability of the N-terminal half of gelsolin (G1-G3) to sever actin filaments in a 
calcium-independent manner suggests that actin itself may participate in the activation of G1-
G3, in contrast with the G4-G6, which must be activated by calcium prior to interactions with 
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actin (Khaitlina et al., 2004; Kolappan et al., 2003; Narayan et al., 2003a; Pope et al., 1995). 
The effect of actin binding on the affinity of gelsolin for calcium also implies that actin can 












The loss of the C-terminal half, when gelsolin is cleaved during apoptosis (Azuma et 
al., 2000; Kothakota et al., 1997), possibly affects the N-terminal half in two ways. First, the 
actin-binding site on G2 becomes accessible. Binding of actin to G2 may induce the 
formation of a helix from the G2-G3 loop, as is shown to be possible by the condensation of 
the equine G2-G3 linker despite the absence of a G2-bound calcium ion (Burtnick et al., 
2004). The change in conformation of the G2-G3 linker may affect the G3 A and B strands 
Figure 3.8. The intra-molecular interactions of inactive and active G3. (A) Hydrophobic 
interactions stabilize the bent conformations of the AB strands, AB loop and long helix of 
inactive G3. The hydrophobic residues forming the core are shown in brown. Asn-278, Asn-
324 and Glu-307 are displayed for comparison with their positions in the active 
conformation. (B) Electrostatic interactions and hydrogen bonds between G3 residues and 
calcium-coordinating waters create a network of interactions that stabilize the G3 active 
conformation. For a more detailed view of the calcium-coordination sphere and interactions, 
please refer to Fig. 3.4. 
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that it is directly connected to, and aid the disruption of, the hydrophobic interactions that 
stabilize the inactive conformation of G3 (Fig. 3.8A). Second, in the absence of the 
constraints imposed by the other domains, the G3 helix may be able to straighten (Wang et 
al., 2009), and form stabilizing interactions with the AB loop (Fig. 3.8B). This would disrupt 
the only latch that resides in the N-terminal half – the G1-G3 latch, and cause the domain 
reorganization of G1-G3 so that it can sever actin filaments even in the absence of calcium.    
Thus, we suggest that the binding of actin to G2 and straightening of the G3 helix are 
key steps in the calcium-independent activation of G1-G3.  
 
G2 – speculation on the causes and effects of binding calcium 
The presence of a bound calcium at the G2 type-II site in the human G1-G3/actin 
structure addresses the conflict presented by the absence of this calcium in the equine G1-
G3/actin structure and studies that have determined that the G2 type-II site has a high affinity 
for calcium (Kd=0.7 µM, Chen et al., 2001; Kd=0.1 µM, Roustan et al., 2007) and can also 
bind calcium mimics such as terbium and cadmium (Chumnarnsilpa et al., 2006; Kazmirski et 
al., 2002). However, while the human G1-G3/actin structure suggests that calcium binding at 
G2 may not be transient, the absence of the G2-bound calcium in the equine structure, while 
lower affinity sites in G1 are occupied, lends itself to speculation. Is it possible, that contrary 
to the suggestion that calcium is released from G2 to achieve the final activated conformation 
(Burtnick et al., 2004), the release of the calcium from G2 is in fact a step towards the 
deactivation of the protein? If the G2 calcium is removed, the residues that form interactions 
with G6 and the C-terminal tail helix will become available to form the contacts required for 
the stabilization of the inactive conformation. Similarly, the other local conformational 
changes induced by the binding of calcium may perhaps be reversed. Unfortunately, in the 
absence of any structure of full-length gelsolin, in either the active or intermediate stages, 
proof for this hypothesis is currently not forthcoming.  
Interestingly, both the structures bearing a cation in the G2 calcium-binding site also 
display a Cys-188 – Cys-201 disulfide bridge (Figs. 3.2C and 3.2D; Kazmirski et al., 2002; 
Chapter 3. Calcium activation of gelsolin – Part I 
 65 
Nag et al., 2009). This disulfide bond is absent from the equine G1-G3/actin structure lacking 
the G2-bound calcium (Burtnick et al., 2004), suggesting that the presence of the disulfide 
bond and a bound calcium at G2 may be correlated. Apart from its expected role in the 
stabilization and folding of G2 (Paunio et al., 1998; Wen et al., 1996; Zapun et al., 2000), the 
Cys-188 – Cys-201 bond has been proposed to enhance the rate of calcium-activation of 
gelsolin although it does not affect the maximal severing rate of gelsolin (Allen, 1997). 
Perhaps, the proximity of the disulfide bond to the calcium-coordinating residue, Asp-187, 
aids the conformational changes induced by calcium-coordination by G2 and stabilizes the 
active conformation, thus enhancing the rate of activation of gelsolin. Conversely, mutations 
in the G2 calcium-binding site do not prevent disulfide bond formation (Isaacson et al., 1999). 
It has been shown that the disulfide bond is present in natural plasma gelsolin but not in 
recombinant plasma or natural cytoplasmic gelsolin (Wen et al., 1996). Additionally, the 
presence of the disulfide bond alters the proteolytic pattern of gelsolin when it is treated with 
plasmin. These findings suggest that the presence of this disulfide bond is associated with 
some conformational change that is, as yet unidentified, but may offer a mechanism for the 
differential modulation of plasma and cytoplasmic gelsolin. 
 
The 3-stage/2-step activation of gelsolin  
Various techniques such as DLS, SAXS and tryptophan fluorescence concur that the 
activation of gelsolin proceeds through two calcium-concentration dependent transitions 
(Ashish et al., 2007; Kiselar et al., 2003a, b; Patkowski et al., 1990; Pope et al., 1997). The 
high-resolution structural information yielded by X-ray crystallography has made it possible 
to dissect these global transitions into the constituent local conformational perturbations. It is 
possible that the first transition in gelsolin structure, associated with the doubling of the 
hydrodynamic radius, coincides with the release of the tail latch and the consequent 
separation of the two halves of gelsolin into two loosely connected globular moieties, while 
the second transition represents the extension of the G1-G2 linker.  
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Chapter 4. Calcium activation of gelsolin – Part II 
4.1  Background 
Many of the calcium-induced conformational changes in gelsolin have been 
elucidated through structural studies and are discussed in Chapter 3. However, the current 
understanding of how calcium mediates these structural changes and activates gelsolin is 
based on conflicting data. Reports disagree about the number of calcium-binding events 
required to activate gelsolin, the calcium concentrations at which different transitions occur, 
and the roles of different sites in the activation process. During activation, gelsolin undergoes 
either two or three conformational changes that are induced at calcium concentrations 
between 10 nM – 5 µM, by the binding of 2 or 3 calcium ions with Kd=0.1, 0.3 and 6.4 µM, 
and completed between 200 µM – 1 mM through binding of 3 – 6 additional calcium ions at 
100 µM (Ashish et al., 2007; Kinosian et al., 1998; Kiselar et al., 2003a, b; Lin et al., 2000). 
Activation of gelsolin requires the release of three main latches, namely, the C-terminal tail 
latch, the G1-G3 latch and the G4-G6 latch. However, while some studies suggest that 
calcium-binding events that occur between 0.1 – 6.4 µM are responsible for the release of the 
tail and G4-G6 latches others suggest that the tail latch is released at micromolar calcium 
concentration and further calcium binding events that occur around 100 µM are necessary to 
spring the G1-G3 and G4-G6 latches (Kinosian et al., 1998; Kiselar et al., 2003a, b; Lin et al., 
2000; Pope et al., 1995). Other reports suggest that unlatching of structural constraints is 
initiated at nanomolar concentrations; yet these are insufficient for activity until low affinity 
calcium binding sites are occupied (Allen and Janmey, 1994; Ditsch and Wegner, 1995; Pope 
et al., 1997).   
The elucidation of the calcium-dependent activity of gelsolin has proven difficult 
because of the complexity of the molecule. Gelsolin has six type-II calcium-binding sites with 
affinities ranging from 0.2 µM to 1 mM; G1 (Kd=0.6 mM, Zapun et al., 2000), G2 (Kd=0.7 
µM, Chen et al., 2001), G4 (Kd=1.8 µM, Pope et al., 1995), G5 (Kd=100 µM, Khaitlina et al.,  
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2004), G6 (Kd=0.2 µM, Pope et al., 1995) and G3 – unknown. Measured affinity for calcium 
can also vary depending on whether the domain is studied in isolation or in the context of the 
other domains as demonstrated by the reports on the affinity of G2 (Kd=0.7 µM, Chen et al., 
2001; Kd=0.1 µM, Roustan et al., 2007; Kd=50 µM, Zapun et al., 2000). Similarly, the affinity 
of G4 varies between Kd=1.8 µM when isolated and Kd=25 nM in the context of G4-G6 (Pope 
et al., 1995). Binding of actin has been reported to alter the affinities of these sites for calcium 
(Pope et al., 1997; Weeds et al., 1995) and may elicit conformational changes in gelsolin. 
Likewise, calcium binding affects both the affinity (Way et al., 1992) and the rate of binding 
of gelsolin to actin (Selden et al., 1998). The kinetics of measured gelsolin activity are also 
affected by the concentration of gelsolin (Gremm and Wegner, 2000). 
However, there is a general consensus about the importance of the C-terminal tail 
helix in the calcium regulation of gelsolin (Burtnick et al., 1997; Kwiatkowski et al., 1989). 
The tail lies within close proximity of the high affinity type-II calcium-binding site of domain 
6 (0.2 µM, Pope et al., 1997). Therefore, it has been suggested that the first calcium-binding 
event is the occupation of the G6 type-II site and this is responsible for springing the latch and 
initiating the activation of gelsolin (Choe et al., 2002; Kolappan et al., 2003; Lagarrigue et 
al., 2003a; Lagarrigue et al., 2003b; Lin et al., 2000; Lueck et al., 2000; Pope et al., 1997). In 
Chapter 3, comparison of the structures of inactive human gelsolin with active G4-G6 and 
G1-G3/actin suggested that the G2 and G6 calcium-binding sites function cooperatively and 
participate in tail-latch release and subsequent activation of gelsolin. Additionally, analysis of 
the structure of active G3 in isolation suggested that through the mechanism of helix-
straightening, G3 may play a role in the release of the G1-G3 latch. In order to further 
investigate the various calcium-binding sites of gelsolin and determine their contribution to 
the activation of gelsolin, mutational analysis of gelsolin was undertaken. The results offer 
interesting insights into the roles of the various type-II calcium binding sites of gelsolin. 
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4.2 Results 
4.2.1 Preparation of gelsolin calcium-binding site mutants 
A series of calcium binding mutants of full-length gelsolin were prepared in order to  
investigate the roles of each type-II calcium-binding site in the activation and function of 
gelsolin. The conserved type-II site aspartate or glutamate was substituted with asparagine 
and glutamine, respectively. The primers used to introduce the mutations are listed in Table 
2.2. Combinations of mutations were obtained through sequential PCR reactions and their 
identities confirmed by sequencing. A comprehensive list of the mutants used in this study is 
presented in Table 4.1. Purified mutants were obtained as described in Chapter 2, Section 









4.2.2 Actin depolymerization assay – an assay for studying the roles of the type-II 
calcium-binding sites of gelsolin 
The actin depolymerization assay was developed in order to observe the activity of 
gelsolin and various calcium-binding mutants of gelsolin in real time. In polymerizing  
Figure 4.1. SDS-PAGE analysis of purified gelsolin mutants. The mutants are numbered 
according to Table 4.1. (A) 15% polyacrylamide gel was used for analysis. (B) and (C) 
12% polyacrylamide gel was used for analysis. Bio-Rad broad range marker was used as 
controls for all runs. 
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Table 4.1 Gelsolin mutants used in this study* 
 Name No. of sites Mutation 
1 GFL 0 wild-type gelsolin, residues 25-755 
2 GTL 0 wild-type gelsolin, residues 25-741 
3 GSMD1 1 D66N 
4 GSMD2 1 D187N 
5 GSMD3 1 D303N 
6 GSMD4 1 D445N 
7 GSMD5 1 D565N 
8 GSMD6 1 D670N 
9 GSME2 1 E209Q 
10 GSME6 1 E692Q 
11 GDMD2D6 2 D187N, D670N 
12 GDMD2E6 2 D187N, E692Q 
13 GDME2D6 2 E209Q, D670Q 
14 GDME2E6 2 E209Q, E690Q 
15 GDMG2 2 D187N, E209Q 
16 GDMG6 2 D670N, E690Q 
17 GDMG4 2 D445N, E475Q 
18 GDMG5 2 D565N, E587Q 
19 GDMD4D5 2 D445N, D565N 
20 GTMG2D6 3 D187N, E209Q, D670N 
21 GTMD2G6 3 D187N, D670N, E692Q 
22 GTMD1E2D6 3 D66N, E209Q, D670Q 
23 GTME2D3D6 3 E209Q, D303N, D670Q 
24 GTME2D4D6 3 E209Q, D445N, D670Q 
25 GTME2D5D6 3 E209Q, D565N, D670Q 
26 GTMG4D5 3 D445N, E475Q, D565N 
27 GTMD4G5 3 D445N, D565N, E587Q 
28 GQMG2G6 4 D187N, E209Q, D670N, E692Q 
29 GQMG4G5 4 D445N, E475Q, D565N, E587Q 
30 GPMD1G2G6 5 D66N, D187N, E209Q, D670N, E692Q 
31 GPMG2D3G6 5 D187N, E209Q, D303N, D670N, E692Q 
32 GPMG2D4G6 5 D187N, E209Q, D445N, D670N, E692Q 
33 GPMG2D5G6 5 D187N, E209Q, D565N, D670N, E692Q 
34 GHMG2G4G6 6 D187N, E209Q, D445N, E475Q, D670N, E692Q 
35 GHMG2D4D5G6 6 D187N, E209Q, D445N, D565N, D670N, E692Q 
36 GHMG2G5G6 6 D187N, E209Q, D565N, E587Q, D670N, E692Q 
 
*Gelsolin mutants were prepared by substituting the conserved aspartate and glutamate 
residues of the calcium-binding sites with asparagine and glutamine, respectively. Each 
gelsolin mutant has a unique alpha-numeric name. The first three letters denote how many 
mutations are contained within the construct – GSM (one), GDM (two), GTM (three), GQM 
(four), GPM (five) and GHM (six). When a single conserved residue within a site is mutated, 
the single letter amino acid code (D for aspartate and E for glutamate) followed by the domain 
number is included, for example, GDMD2E6 has two mutations, the conserved aspartate of 
domain 2 and conserved glutamate of domain 6 have been substituted to asparagine and 
glutamine, respectively. When both the conserved aspartate and glutamate of a particular 
domain have been substituted, it is represented by G followed by the domain number, for 
example, GDMG2 has two mutations, the aspartate and glutamate of domain 2 have been 
substituted. 
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conditions, the fluorescence emission of pyrene-labeled F-actin remains relatively constant 
over the time scale of the experiment (a total decrease of ~ 4% in fluorescence intensity), due 
to dynamic treadmilling, which maintains the length of the filaments (black curve, Fig. 4.2). 
When activated by calcium, gelsolin, through its actin filament severing and monomer 
binding properties, can dismantle the filaments resulting in a measurable decrease in 
fluorescence intensity. In the absence of calcium, gelsolin is inactive and is expected to have 
no effect on actin filaments and consequently display no decrease in fluorescence intensity. 
To test the efficacy of the assay, the activity of gelsolin (GFL) and a deletion mutant lacking 
the C-terminal tail helix (GTL), in EGTA and in calcium, were investigated. The protein of 
interest was added in a molar ratio of 1:2 to pyrene-labeled F-actin and depolymerization of 
the labeled filaments was measured as the decrease in fluorescence intensity as a function of 
time. As expected, GFL was active in calcium as demonstrated by the ~ 90% decrease in 
fluorescence intensity within two minutes of mixing with F-actin (light blue, Fig. 4.2). In 






Figure 4.2. F-actin depolymerization assay. GFL (full-length wild-type cytoplasmic 
gelsolin) and GTL (tail-less gelsolin) were added at a molar ratio of 1:2 with pyrene-labeled 
F-actin (4 µM) in EGTA and activity measured as the decrease in fluorescence intensity. 
The experiment was repeated with GFL in calcium (GFL-Ca) to define the difference in 
activity in the presence and absence of calcium.  
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an initial decrease (~ 17%) in fluorescence intensity before stabilization (dark blue, Fig. 4.2). 
This basal level of activity can likely be attributed to the calcium-independent actin severing 
and binding activity of the N-terminal half of gelsolin, produced by auto-cleavage of gelsolin. 
Interestingly, GTL was partially active in EGTA (orange, Fig. 4.2) demonstrating a slow 
decrease of ~ 60% in fluorescence intensity in the course of 1 h. The greater depolymerization 
activity of GTL in initial phase (< 5 min), is possibly a combination of activity from cleaved 
halves with severing activity of partially active full-length GTL. In the presence of calcium, 
GTL has activity comparable to GFL (red, Fig. 4.2). The initial depolymerization observed 
for gelsolin is possibly a result of the calcium-independent activity of the small percentage of 
cleaved halves, within the protein samples. 
The clearly discernible differences in the activities of GFL and GTL in EGTA and in 
calcium, suggest that this assay is appropriate for determining which calcium-binding sites 
contribute to the activation of gelsolin. It is expected that mutants, with substitutions within 
the crucial calcium-binding sites, are expected to display variation in activity as compared to 
GFL and perhaps allow the identification of the sites critical for the release of the tail-latch.  
 
4.2.3 G2 and G6 calcium-binding sites contribute to gelsolin activity 
Inspection of the G2-G6 interface within the structure of calcium-free human gelsolin 
and comparison with active G2 (G1-G3/actin structure) and G6 (G4-G6 structure,Narayan et 
al., 2003) suggested that G2 and G6 bind calcium cooperatively and participate in gelsolin 
activation (discussed in Chapter 3). The actin depolymerizing activity of various G2 and G6 
calcium-binding site mutants of gelsolin, was therefore, analyzed in the presence of EGTA 
and EGTA-buffered calcium.  
Mutants containing one (GSMD2, GSME2, GSMD6, GSME6) mutation within G2 or 
G6 exhibit activity similar to the GFL control in EGTA (Fig. 4.3A). Two-site mutants 
(GDMG2, GDMG6, GDMD2D6, GDMD2E6, GDME2D6, GDME2E6) displayed slightly 
more variation with reduction in fluorescence intensity ranging from ~ 17% - 25% (Fig. 
4.3B). In contrast, mutants in which three conserved residues of the G2 and G6 sites have  









Figure 4.3. Assessment of depolymerization activity of mutants with substitutions in G2 and 
G6, in EGTA. (A) Mutants containing a single mutation within G2 or G6. (B) Mutants with 
two substitutions within G2 and G6. (C) Mutants with three or four substitutions across G2 
and G6.  
 








Figure 4.4. Assessment of depolymerization activity of mutants with substitutions in G2 
and G6, in 10 µM EGTA-buffered free calcium. (A) Mutants containing a single mutation 
within the calcium-binding site of G2 or G6. (B) Mutants with two substitutions within 
G2 and G6. (C) Mutants with three or four substitutions across G2 and G6.  
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been mutated (GTMG2D6, GTMD2G6) display low levels of actin-depolymerization activity 
in EGTA reducing fluorescence intensity by ~ 33% in 1h (Fig. 4.3C). The mutant with all 
four conserved residues of G2 and G6 mutated (GQMG2G6), displays the greatest activity 
amongst the G2 and G6  mutants tested (~ 50% reduction in fluorescence intensity), but is 
less active than GTL. In 10 µM EGTA-buffered calcium, all the mutants tested display 
activity comparable to GFL and GTL (Figs. 4.4A, 4.4B and 4.4C). 
The minimum requirement of three mutations across G2 and G6 for discernible 
activity, suggests that the two domains function cooperatively and have a role in gelsolin 
activation. However, the activity of GQMG2G6, wherein all four conserved residues have 
been substituted, is lower than GTL, implying that at least one other site is involved in the 
release of the tail-latch and activation of gelsolin. That all the mutants have activity 
comparable activity to GFL and GTL in calcium suggests that the substitutions are 
conservative and do not affect the folding and function of the proteins in the conditions tested.  
 
4.2.4 Different domains of gelsolin may have conflicting roles 
To ascertain calcium-binding sites other than G2 and G6 that participate in the activation of 
gelsolin, single mutants of the other sites (GSMD1, GSMD3, GSMD4, GSMD5) were 
prepared. A second batch of mutants with three substitutions each, a G2 and a G6 type-II site 
mutation with an additional mutation in G1, G3, G4 or G5 (GTMD1E2D6, GTME2D3D6, 
GTME2D4D6, GTME2D5D6) were also analyzed to identify additive effects on gelsolin 
activation. As with the mutants containing a single substitution within G2 or G6, single 
mutations within the other four domains have no distinguishable effect on the activity of 
gelsolin in EGTA (Fig. 4.5A). The three-site mutants however, display activity comparable to 
previously tested G2-G6 mutants that have three mutations located within G2 and G6 (Fig. 
4.5B), with reduction in fluorescence intensity ranging from 30 % to 40 %. That single 
mutations have no effect on the activity of gelsolin, while the three-site mutants studied 
display a small variation in activity, irrespective of the domains in which they are located, 
suggests that gelsolin activation requires the cooperation of the calcium-binding sites and  










Figure 4.5. F-actin depolymerization assay conducted in the presence of EGTA. (A) 
Mutants with a single substitution within the calcium-binding site of G1, G3, G4 or G5. (B) 
Mutants containing three substitutions, two within G2 and G6 and the third in G1, G3, G4 
or G5. (C) Mutants containing five substitutions; two each within G2 and G6 and the fifth 
in G1, G3, G4 or G5.  
 










Figure 4.6. F-actin depolymerization assay conducted in the presence of 10 µM EGTA-
buffered free calcium. A) Mutants with a single substitution within the calcium-binding site 
of G1, G3, G4 or G5. (B) Mutants containing three substitutions, two within G2 and G6 and 
the third in G1, G3, G4 or G5. (C) Mutants containing five substitutions; two each within 
G2 and G6 and the fifth in G1, G3, G4 or G5.  
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cannot be effected by any of the sites alone. However, three mutations distributed over three 
domains are insufficient to achieve levels of activation comparable to GTL. To overcome this 
issue, a batch of mutants comprising five mutations each (GPMD1G2G6, GPMG2D3G6, 
GPMG2D4G6, GPMG2D5G6) was prepared with GQMG2G6 as a template to identify 
domains that, in combination with double mutations in G2 and G6, activate gelsolin. 
Interestingly, the five-site mutants exhibited widely varying levels of activity in 
EGTA (Fig. 4.5C). GPMG2D5G6 (additional mutation within G5) and GPMG2D4G6 
(additional mutation within G4) are significantly more active than GTL, reducing 
fluorescence intensity by ~ 85% and ~ 80%, respectively, while GPMD1G2G6 (additional 
site within G1) displays a level of activity similar to GTL (~ 60% reduction in fluorescence 
intensity). Interestingly, the activity of GPMG2D3G6 (additional site within G3) is 
considerably lower than the other five-site mutants. Displaying a ~ 35% reduction in 
fluorescence intensity over 1 h, GPMG2D3G6 has lower activity than both GTL and the four-
site mutant GQMG2G6, and in the range of the three-site mutants. In 10 µM EGTA-buffered 
calcium, all the mutants displayed indistinguishable activity (Figs. 4.6A, 4.6B and 4.6C).  
The remarkable increase in the activity of GQMG2G6, caused by a single additional mutation 
within G4 or G5 suggests that these two domains contribute significantly to the activation of 
gelsolin. That the activity of GPMG2D4G6 and GPMG2D5G6 is considerably higher than 
GTL also implies that these mutants have undergone additional activation events apart from 
the release of the tail-latch. In contrast, the additional mutation in G3 appears to counteract 
the effects of the mutations within G2 and G6, with GPMG2D3G6 displaying ~ 35% activity 
opposed to ~ 50% of GQMG2G6. This finding prompted a closer look at the activity of the 
three-site mutants. Within the small variation displayed by the three-site mutants (Fig. 4.5C), 
GTME2D3D6 displays the lowest activity while GTME2D4D6 and GTME2D5D6 display the 
highest activity in consensus with the data from the five-site mutants. 
 
4.2.5 GQMG4G5 has activity comparable to GTL 
Two-, three- and four-site mutants across G4 and G5 were prepared to define the role  







Figure 4.7. Analysis of mutants with substitutions in G4 and G5 (A) F-actin 
depolymerization assay conducted in the presence of EGTA. Activity of mutants containing 
one to four substitutions within the calcium-binding sites of G4 and G5 is compared. (B) and 
(C) F-actin depolymerization assay conducted in the presence of 10 µM EGTA-buffered free 
calcium to assess the activity of the G4 and G5 mutants in calcium.  
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these two domains. At a ~ 25% reduction in fluorescence intensity, GDMG4 (G4 aspartate 
and glutamate substituted) and GDMG5 (G5 aspartate and glutamate substituted) display 
activity within the range previously observed for G2-G6 double mutants (Fig. 
4.7A).GDMD4D5 (aspartate of G4 and G5 substituted) is more active reducing fluorescence 
intensity by ~ 30% in 1h, suggesting that the two sites may function cooperatively. The three-
site mutant bearing two mutations within G5, GTMD4G5, has activity comparable to 
GQMG2G6 (~ 45 % reduction in fluorescence intensity) and is more active than GTMG4D5 
(~ 35% reduction in fluorescence intensity). GQMG4G5, wherein the conserved aspartate and 
glutamate of both G4 and G5 have been substituted, depolymerizes F-actin to a similar extent 
to GTL. In calcium, the activity of these mutants is comparable to GFL (Figs. 4.7B and 4.7C). 
 
4.2.6 Six-site mutants can depolymerize actin to the same extent as activated GFL 
The range of activity displayed by the five-site mutants and previous results that 
repeatedly emphasized the cooperativity between different calcium-binding sites prompted 
the preparation and analysis of mutants with six mutations. GHMG2G5G6 (aspartate and 
glutamate of G2, G5 and G6 are substituted) displays the highest activity, achieving ~ 90% 
decrease in fluorescence intensity within 40 minutes (Fig. 4.8A). GHMG2D4D5G6 (aspartate 
of G2, G4, G5 and G6 and glutamate of G2 and G6 substituted) achieves similar decrease in 
fluorescence intensity within 1h. Both these mutants depolymerize F-actin to the same extent 
in EGTA as GFL does in calcium although the latter is about 20 times faster than the mutants. 
GHMG2G4G6 (aspartate and glutamate of G2, G4 and G6 substituted) displays similar 
activity to GPMG2D4G6, achieving ~ 80% decrease in fluorescence intensity in 1h. 
GHMG1G2G6 (two substitutions each within G1, G2 and G6) and GHMG2G3G6 (two 
substitutions each within G2, G3 and G6) are yet to be tested. Despite containing six 
mutations each, these mutants exhibit activity comparable to GFL in calcium (Fig. 4.8B). 
 
4.2.7 The six-site gelsolin mutants sequester monomers but do not nucleate filaments  
Actin monomer sequestration and filament nucleation assays were conducted to define the  








level of activation of selected gelsolin mutants. To check for nucleation, GFL, GTL and 
various mutants were incubated with G-actin (4 µM) at a molar ratio of 1:100 for 10 minutes 
in the absence of calcium, before inducing polymerization. As a control, GFL was also 
incubated at 1:2 molar ratio with actin, in calcium for 10 minutes. None of the mutants tested 
displayed nucleation activity in EGTA (Fig. 4.9A), while GFL was able to nucleate filaments 
only in buffer containing calcium.  
To test for monomer sequestration activity, GFL and its mutants were incubated with  
Figure 4.8.  Analysis of six-site mutants (A) F-actin depolymerization assay conducted in 
the presence of EGTA. The mutants analyzed contain six substitutions distributed across 
G2, G4, G5 and G6. (B) F-actin depolymerization assay conducted in the presence of 10  
µM EGTA-buffered free calcium.  
 











Figure 4.9. Assessment of gelsolin mutants through alternate functional assays. (A) Actin 
filament nucleation assay in the absence of calcium. Proteins of interest were incubated 
with G-actin (4 µM) at a molar ratio of 1:100 for 10 minutes before inducing 
polymerization. GFL activity was tested in both EGTA and calcium. (B) and (C) Actin 
monomer sequestration assay in the absence of calcium. Proteins of interest were incubated 
with G-actin (4 µM) at a molar ratio of 1:2 for 15 minutes (B) and 45 minutes (C) before 
inducing polymerization. GFL activity was tested in both EGTA and calcium. 
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G-actin (4 µM) at a molar ratio of 1:2 for 15 minutes and 45 minutes, before inducing 
polymerization. GHMG2G5G6 and GHMG2D4D5G6 were able to sequester monomers and 
prevent polymerization, after incubation with G-actin for 15 minutes, as effectively as GFL in 
calcium (Fig. 4.9B). GHMG2G4G6 also displayed significant monomer sequestration activity 
after 15 minutes but required a longer incubation period to achieve complete sequestration 
(Figs. 4.9B and 4.9C). Like GHMG2G4G6, GTL displayed increased sequestration in EGTA 
with increased incubation period. GQMG4G5 displayed a small increase in sequestration, 
from ~ 50% fluorescence intensity after 15 minutes incubation to ~ 40% after 45 minutes. 
However, while GQMG2G6 displayed some monomer sequestration, its activity was not 




Calcium-binding mutants have activity in the absence of calcium 
The substitution of the carboxylate groups of aspartate and glutamate with the amide 
groups of asparagine and glutamine, respectively, was expected to interfere with calcium 
coordination and increase the calcium requirement for activation, thus permitting the 
segregation of sites that elicit the conformational changes of gelsolin. Contrary to expectation, 
the mutations activate gelsolin, if only partially, most likely through a combination of 
mechanisms. In the inactive conformation, the conserved calcium-binding residues form inter- 
and intra-domain interactions that stabilize the protein (Fig. 3.7). Replacement of the 
negatively charged residues may be responsible for weakening intra-molecular interactions 
that stabilize the inactive structure. Although in the active protein, calcium-coordination 
stabilizes the protein structure, in the transition stages, calcium binding must destabilize the 
inactive conformation to allow the rearrangements necessary for activation. It is, therefore, 
possible that asparagine and glutamine induce conformational changes leading to the 
activation of gelsolin because their high propensity to form hydrogen bonds results in contacts 
that mimic calcium coordination. Although functional assays cannot define the contribution of 
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the different mechanisms to the activity of the mutants, the minimum requirement of three 
mutations to activate the protein, and the comparable activity of all the mutants analyzed in 
calcium, suggest that the mutations do not drastically affect the stability of the protein. 
Structural analyses of the mutants are currently underway to determine if the mutations mimic 
calcium-coordination, as well as to elucidate intermediate conformations of gelsolin.  
 
Conformational changes induced by calcium binding to various domains 
 The C-terminal tail participates in the calcium regulation of gelsolin (Kwiatkowski et 
al., 1989). The structure of inactive gelsolin shows that the tail holds the two halves of the 
protein together through interactions with G2 (Fig. 3.7, Burtnick et al., 1997; Nag et al., 
2009). Superimposing the structure of inactive gelsolin without the tail on actin demonstrates 
that clashes with G6 should prevent G2 from binding actin, thus keeping gelsolin inactive 














demonstrated by the ability of GTL to partially depolymerize F-actin and sequester monomers 
(Figs. 4.2, 4.9B and 4.9C) as well as sever filaments (Lin et al., 2000), suggesting that GTL 
Figure 4.10. Model of tail-less gelsolin (GTL) bound to actin. In the closed conformation 
displayed by inactive gelsolin, in the absence of the tail, G6 clashes with actin, preventing 
interactions between G2 and actin. 
Chapter 4. Calcium activation of gelsolin – Part II 
 84 
adopts a conformation that allows G2 to access actin. It is likely that the absence of the 
interactions between the tail and G2 allows the two halves of gelsolin to move more freely 
with respect to each other and possibly exist in dynamic equilibrium between an open 
conformation, wherein the G2 actin-binding site is exposed, and a closed conformation 
similar to inactive gelsolin. This is supported by the increased monomer sequestration 
displayed by GTL after a longer period of incubation with actin. Since G2 contains an F-actin 
binding site (Way et al., 1992b), GTL is unable to prevent the initial polymerization of actin 
but possibly binds to and caps short filaments preventing the further polymerization of actin 
(Fig. 4.9B). In combination, these results provide evidence that when the tail is released or 
absent, gelsolin dynamically shifts between open and closed conformations and therefore, is 
partially active in the absence of calcium. 
 An increase in monomer sequestration with longer incubation is also observed for 
GHMG2G4G6, suggesting that the tail-latch has been released in this mutant as well as in 
GHMG2G5G6, which displays higher activity than the former in both filament 
depolymerization and monomer sequestration assays (Figs. 4.9B and 4.9C). When the activity 
of the five-site and six-site mutants, containing substitutions in G2, G4 and G6 or G2, G5 and 
G6, is compared to that of the four-site mutants, GQMG2G6 and GQMG4G5, it is evident 
that both G4 and G5, cooperate synergistically with G2 and G6 during the activation of 
gelsolin (Figs. 4.5C and 4.8A). Comparison of the structures of inactive and active G4 and G5 
offers clues to the structural mechanisms underlying the observed synergy.  
In the inactive conformation, Asp-445 and Glu-475, the conserved G4 calcium-
coordinating residues, interact with Arg-526 from the G5 A′-A loop, stabilizing this 
conformation (Fig. 4.11A). Substitution of these residues with asparagine and glutamine, 
coordination, may also cause the G5 A′-A loop to be repositioned into the active 
conformation (Fig. 4.11B). It is possible that these new contacts will result in the rotation of 
G4 with respect to G6 thus breaking the G4-G6 latch and repositioning the G4 long helix so 
that it is accessible to actin (Fig. 4.11C). Simultaneous activation of G6, as in the case of  











Figure 4.11. Proposed mechanism for activation of gelsolin by mutation of conserved G4 
residues. (A) The interface between G4 (pink) and G5 (green). The calcium-binding residues 
of G4 and the interacting residue from the G5 A'-A loop are highlighted and labeled. (B) 
Active G5 (brown) is superimposed upon inactive G5 to demonstrate how the substitution of 
the conserved aspartate and glutamate may mimic the presence of a calcium ion and cause the 
G5 A'-A loop to be repositioned. (C) Active G4 (teal) from active G4-G6 superimposed on 
G5, displays the rotation between inactive and active G4 that could weaken the interactions 
between the β-sheets of G4 and G6 (orange). The direction of displacement of G4 long helix 
and G5 A'-A loop are shown by teal and brown arrows, respectively. 
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GHMG2G4G6, possibly results in tail-latch release. This may permit GHMG2G4G6 to 
display greater filament depolymerization activity than GTL, but a similar time-dependent 
increase in monomer sequestration.  
Asp-565, one of the conserved calcium-coordinating residues of G5, interacts with 
Arg-629 from the G5-G6 linker (Fig. 4.12A). Activation through calcium binding causes the 
G5-G6 linker to condense pulling G6 to its activated position adjacent to G5. In this 
conformation Arg-629 is repositioned so that it forms bonds with the backbone oxygen of 
His-638 and Thr-676 from G6 thus stabilizing the G5-G6 interface (Figs. 4.12B and 4.12C). 
Substitution of Asp-565 and Glu-587 possibly mimics activation, resulting in the 
condensation of the G5-G6 linker. In the absence of G6 activation, the tail-latch holds G6 in 
its position next to G4. However, when mutations are present in G5, G6 and G2, as in the case 
of GHMG2G5G6, the proposed condensation of the G5-G6 linker, without the tail-latch to 
prevent the movement of G6, may result in the reorganization of the C-terminal half of 
gelsolin and consequent activation. Interestingly, despite the similar actin depolymerization 
activity of GQMG4G5 and GTL the monomer sequestration activity of the former, unlike 
GTL, displays only a small increase within the same duration (Figs. 4.9B and 4.9C) indicating 
that the GQMG4G5 tail-latch may still be bound to G2, although the interactions may be 
weakened by the mechanisms proposed earlier. GQMG2G6 displays lower activity than GTL 
and GQMG4G5 in both assays (Figs. 4.7A and 4.9B) suggesting that the tail-latch is intact in 
this mutant. Consequently, it seems reasonable to propose that the cooperative activation of 
G4, G2 and G6 or G5, G2 and G6 is necessary to spring the tail-latch. The contribution of G2 
and G6 to the tail-latch release is unclear. That the two sites cooperate is evident, both from 
the proximity within the structure (Fig. 3.7) and the actin depolymerization assay (Fig. 4.3C), 
but whether this cooperation is merely a consequence of weakening inter-domain interactions 
or inducing activating changes in conformation, remains unknown. Another point to note is 
that while the mutations are activating, the effects they elicit may be weaker than those 
induced by calcium binding. If this is indeed the case, the binding of calcium to G2 and G6 
alone, may be sufficient to spring the tail-latch. 
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The roles of G1 and G3 in the activation of gelsolin remain unexplored. G3 is of 
particular interest because of the unique behavior that GPMG2D3G6 mutant displays, 
decreasing the activity of GQMG2G6 (Fig. 4.5C). Additionally, the slow depolymerization of 
actin filaments and lack of nucleating ability of even the most active mutants also suggests 
that they are only partially active and that complete activation may require additional sites. 
These results agree with the mechanism of activation proposed by Ashish et al. (2007) where 
they suggest that during activation gelsolin unwinds from both ends and the extension of the 
G3-G4 linker is the last step in the process.  
This study, although by no means complete, has provided some interesting clues to 
the mechanism of activation of gelsolin. However, confirmation of the proposed roles of the 
various domains would require high-resolution structural information. To this end, structural 
characterization of selected mutants is currently underway. 
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Chapter 5. Adseverin and scinderin-like B offer insights into the 
structure, function and regulation of the gelsolin family  
 
5.1 The adseverin C-terminal half imitates the structure and actin-binding 
mechanism of gelsolin 
[The work presented in this section of Chapter 5 has been published (Chumnarnsilpa et al., 
2009). The abstract of the publication is enclosed in the Appendices] 
 
5.1.1 Background - Adseverin and gelsolin: homologous sequences, variable function 
and regulation   
  First identified in bovine adrenal medulla, adseverin’s primary function is to 
disintegrate the cortical actin network of chromaffin cells, in a calcium-dependent manner, 
and allow secretory vesicles to access the plasma membrane and disgorge their contents 
through exocytosis (Maekawa and Sakai, 1990; Rodriguez Del Castillo et al., 1990; Pene et 
al., 2005). The actin regulatory functions, domain architecture and distribution of various 
functional motifs of adseverin mirror those of gelsolin (Sakurai et al., 1991b). Surprisingly 
however, an adseverin fragment comprising only domains 5 and 6 was reported to nucleate 
actin filaments (Lejen et al., 2002; Marcu et al., 1998) while gelsolin requires domains 2-6 for 
efficient nucleation (Way et al., 1989). Another key distinction in the functions of these two 
proteins lies in the inability of the N-terminal half of adseverin to sever F-actin in a calcium 
independent manner (Sakurai et al., 1991a). Also, unlike gelsolin whose function is inhibited 
by phosphatidylinositol 4-monophosphate (PIP) and phosphatidylinositol 4,5-biphosphate 
(PIP2), adseverin has two additional inhibitors in phosphatidylinositol (PI) and 
phosphatidylserine (PS) (Janmey et al., 1987; Janmey and Stossel, 1987; Maekawa and Sakai, 
1990).  
Adseverin has often been called the “tail-less gelsolin” in literature because of the 
conspicuous absence of the gelsolin C-terminal helical tail. The significant structural role of 
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the tail in the calcium regulation of gelsolin has been discussed in detail in Chapters 3 and 4. 
Due to the presence of the tail, gelsolin has two rate-limiting steps during calcium-dependent 
activation, while adseverin has one (Lueck et al., 2000). The presence of the tail also 
introduces greater temperature sensitivity to gelsolin activation. Gelsolin demonstrates a 8-
fold increase in severing rate per 10°C increase in temperature opposed to the 2-fold increase 
in severing rate demonstrated by adseverin for the same temperature variation. Truncation of 
the tail is reported to eliminate these calcium regulatory differences between gelsolin and 
adseverin (Lueck et al., 2000).  
The similarities between gelsolin and adseverin suggest that their structures and 
activation mechanisms are alike. However, the significant differences, both in sequence 
(missing C-terminal helix in adseverin) and function (filament nucleating ability of A5-A6, 
calcium-dependent activity of N-terminal half of adseverin) beg the question; despite the high 
sequence homology, does adseverin have a different domain arrangement?  
The recently solved structure of the C-terminal half of adseverin (A4-A6) 
(Chumnarnsilpa et al., 2009), partially answers this question. It reveals that the structure of 
activated A4-A6 emulates that of the C-terminal half of gelsolin (G4-G6). The overall 
topology of A4-A6 and G4-G6 and the positions of the calcium-binding sites in the tertiary 
structure are identical (Fig. 5.1). The resemblance in the key structural features of G4-G6 and 
A4-A6 and superimposition of the A4-A6 structure upon that of the G4-G6/actin complex 
(Robinson et al., 1999) strongly suggest that A4-A6 has a major actin binding site within the 
A4 long helix and a minor actin-binding site in A6, similar to gelsolin (Fig. 5.2). In this study, 
the activity of adseverin, gelsolin and several truncates of these two proteins were compared 






















Figure 5.1. Structure of activated adseverin C-terminal half. (A) Schematic representation 
of A4-A6. Ca2+ are shown as black spheres. (B) The structure of G4-G6 for comparison 
(PDB ID 1P8X). (C) C-α superimposition of A4-A6 and G4-G6 with color coding similar 
to A and B. 
 
Figure 5.2. Model of actin-binding by calcium-bound A4-A6. The structure of A4-A6 
docked on actin (green surface) in accordance with the G4-G6/actin structure PDB ID 
1H1V. Magnified representations of the regions of contact from A4 (schematic) and A6 
(charged surface) with actin are shown in comparison to the homologous regions from 
gelsolin. In particular, the conserved residue Asp-461 (Asp-487 gelsolin), mediates 
calcium binding with actin. The residues targeted for mutational analyses (Phe-455, 
adseverin and Ile-481, gelsolin) are labeled. The yellow strand within A5, indicated by 
an arrow, depicts the actin nucleating fragment from A5 (Marcu et al., 1998). 
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5.1.2 Results     
5.1.2.1 Actin-binding by adseverin mirrors actin-binding by gelsolin 
To establish the actin-binding interfaces on A4-A6, suggested by the structure of A4-
A6, actin monomer sequestration activity of A4-A6 was compared with that of a mutant, A4-
A6M, containing an actin interaction-disrupting mutation (Phe455Asp) within the A4 long 
helix of A4-A6. To further establish the parallel actin-binding mechanisms of adseverin and 
gelsolin, the monomer sequestration activities of G4-G6 and G4-G6M, a construct with a 
mutation (Ile481Asp) within the G4 long helix of G4-G6 corresponding to that of A4-A6M, 
were also analyzed (Fig.  5.3A). If A4-A6 binds actin through hydrophobic interactions of the 
long helix of A4, like gelsolin, the replacement of a crucial hydrophobic residue with a 
charged amino acid should make the mutants A4-A6M and G4-G6M incapable of actin 
monomer sequestration.  
Not surprisingly, both A4-A6 and G4-G6, when incubated at a molar ratio of 1:1 with 
G-actin, prevented actin polymerization as evidenced by the absence of an increase in 
fluorescence. Similarly, full-length adseverin and gelsolin prevent actin polymerization when 
incubated with G-actin at molar ratios of 1:2. In contrast, incubation of G-actin with either 
A4-A6M or G4-G6M, has no effect on actin polymerization, which occurs similarly to the 
actin control (Fig. 5.3A). These data demonstrate that full-length adseverin and gelsolin as 
well as A4-A6 and G4-G6 sequester monomeric actin, thus preventing polymerization, and 
that the single mutation in the long helix of A4 and G4 completely abolishes actin monomer 
sequestration by A4-A6 and G4-G6, respectively.  
 
5.1.2.2 Adseverin A5-A6 is unable to nucleate actin filaments 
The structure of A4-A6 is similar to that of G4-G6 in the G4-G6/actin structures, 
wherein G5 has no interaction with actin, suggested that A5 does not contain an actin-binding 
site. This was supported by the complete abrogation of actin binding by a single mutation in 
A4 and led to the re-examination of the filament nucleating activity of adseverin domains 5-6  












Figure 5.3. Biochemical analyses of adseverin. (A) and (B) Actin monomer sequestration 
assay. G-actin (6 µM) was incubated at a 2:1 molar ratio with adseverin and gelsolin and a 
1:1 molar ratio with G4-G6, A4-A6, G4-G6M, A4-A6M, G5-G6 and A5-A6 for 30 min 
before induction of polymerization. Actin, gelsolin and adseverin controls are presented in 
both A and B. G4-G6, G4-G6M, A4-A6, and A4-A6M are shown in A and G5-G6 and A5-
A6 are shown in B for clarity. (C) and (D) Actin nucleation assay. G-actin (6 µM) was 
incubated at a 100:1 molar ratio with adseverin, gelsolin, A4-A6, G4-G6, A5-A6 and G5-
G6 for 10 min before inducing polymerization. Actin, gelsolin and adseverin controls are 
shown in both C and D. G4-G6 and A4-A6 are shown in C and G5-G6 and A5-A6 are 
shown in D for clarity. (E) Actin depolymerization assay. F-actin (12 µM) was incubated 
with 2:1 molar ration of adseverin and gelsolin and 1:1 molar ratio with A1-A3 and A4-A6 
and titrated against an EGTA-buffered calcium gradient.  
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 (A5-A6). In order for a protein to nucleate filament formation, it must bind at least two actin 
monomers. Therefore, for A5-A6 to nucleate actin filaments, an actin-binding site other than 
the minor site on A6 has to be present. In order to explore the possibility that in the absence 
of A4, A5-A6 adopts a conformation that differs from that within A4-A6, and interacts with 
two actin monomers to nucleate filament formation, the actin monomer sequestration activity 
and actin filament nucleation activity of A5-A6 and the corresponding gelsolin fragment G5-
G6 were analyzed. 
Full-length adseverin and gelsolin nucleate filaments efficiently when incubated with 
G-actin at molar ratios of 1:100, as evidenced by the elimination of the lag phase in the actin 
polymerization observed through the real-time measurement of fluorescence intensity (Figs. 
5.3C and 5.3D). In these conditions, none of the fragments investigated (A5-A6, A4-A6, G5-
G6 and G4-G6) exhibit nucleating activity (Figs. 5.3C and 5.3D). Instead, the initial rate of 
polymerization of actin is slightly lower in the presence of these fragments, suggesting low 
levels of G-actin sequestration. The G-actin sequestration activity of A5-A6 and G5-G6 was 
therefore investigated. When incubated at molar ratios of 1:1 with G-actin, both A5-A6 and 
G5-G6 are incapable of sequestering monomers and thereby preventing actin polymerization 
(Fig. 5.3B).  
 
5.1.2.3 The N-terminal half confers calcium regulation on adseverin 
Despite the structural and functional similarities that exist between the C-terminal 
halves of gelsolin and adseverin, it is known that these two proteins display differences in 
calcium-sensitivity. In order to investigate these differences, a steady-state pyrene-labeled F-
actin depolymerization assay was conducted across a calcium-gradient. Full-length adseverin 
and full-length gelsolin at molar ratios of 1:2, and A1-A3 and A4-A6 at molar ratios of 1:1 
with F-actin were titrated across an EGTA-buffered calcium gradient. Adseverin and A1-A3 
demonstrated similar actin-depolymerization activity and were activated at nearly 3-fold 
lower free calcium concentrations compared with gelsolin (Fig. 5.3E), with mid-points of the 
transitions occurring at 0.06 µM (A1-A3), 0.08 µM (adseverin) and 0.2 µM (gelsolin). A4-A6 
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was activated at 20-fold higher calcium concentration when compared to adseverin and A1-
A3 (mid-point at 1.5 µM). Time required to reach steady state in the presence of the different 
constructs also displayed wide variation: 2 h (A1-A3), 5 h (adseverin and gelsolin), 24 h (A4-
A6). 
 
5.2 The structure of calcium-free scinderin-like B 
5.2.1 Background – Divergent sequences, novel functions – scinderin-like genes from 
zebrafish 
An unusual role related to vision for gelsolin family proteins was discovered with the 
identification of a gelsolin-like protein, C/L-gelsolin, in the cornea of zebrafish (Xu et al., 
2000). Later, phylogenetic analyses placed C/L-gelsolin in an independent outgroup more 
closely related to adseverin (also known as scinderin), than gelsolin (Jia et al., 2007) and 
persuaded the authors to rename it scinderin-like A (scinlA). As is common with fish genes, 
due to a whole genome duplication event in early teleost evolution (Taylor et al., 2003), 
scinlA has a closely related analog, scinlB (Jia et al., 2007). ScinlA comprises about 40% of 
the soluble protein in zebrafish corneal epithelium (Xu et al., 2000). While actin is also 
abundant, at 15% its expression levels are considerably lower than scinlA. ScinlB is also 
preferentially expressed in the cornea, albeit at much lower levels than scinlA. The abundant 
corneal accumulation of specific proteins, analogous to lens crystallins, suggests that these 
proteins have a structural role for corneal transparency (reviewed in Piatigorsky 2001). Like 
other lens and corneal crystallins, scinlA and scinlB are also expressed in other tissues and 
have non-structural functions. In particular, these two proteins play important roles in 
zebrafish development, with reduction in scinlA expression being associated with embryo 
ventralization and reduction in scinlB expression being correlated to brain abnormalities 
associated with cell death, decreased sonic hedgehog-B expression in the floor plate and 
reduced eye distance (Jia et al., 2007).  
 The novel structural role of scinlA and scinlB as corneal crystallins is unique within 
the gelsolin family. The formation of large ordered networks by a gelsolin family protein is 
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also contrary to the customarily dynamic nature of the proteins of this family. It is therefore 
possible that significant structural variations exist between the zebrafish scinderin-like and the 
mammalian gelsolin family proteins. However, the non-structural functions of these proteins 
may be actin-dependent and require the conservation of structural characteristics necessary 
for actin-related functions. The intriguing combination of conserved and diversified function 
has prompted the structural analysis of the zebrafish scinderin-like proteins.  
  
5.2.2 Results 
5.2.2.1 Sequence comparison of scinlA and scinlB with adseverin and gelsolin 
The sequences of scinlA and scinlB were aligned with those of human adseverin and 
human gelsolin using ClustalW (Fig. 5.4). ScinlA and scinlB are 71% identical to each other. 
ScinlA has a 58% identity with both human adseverin and human gelsolin. ScinlB has a 59% 
identity with human adseverin and a 57% identity with human gelsolin. All the conserved 
aspartate and glutamate residues from the type-I and type-II calcium-binding sites of gelsolin 
are present in scinlA, scinlB and adseverin. The only exception is the domain 3 type-II site 
aspartate that is substituted by a glutamate in scinlB and adseverin (Fig. 5.4). Intriguingly, 
both scinlA and scinlB have a 12 residue C-terminal extension compared to adseverin. This 
extension aligns with residues 743-753 of gelsolin, which form the helical tail-latch in the 
inactive gelsolin structure. 
 
5.2.2.2 Protein preparation and crystallization 
Purified scinlA and scinlB, at 10 mg/ml and 17 mg/ml, respectively, were set up for 
crystallization trials (Fig. 5.5A). A large single crystal of scinlB that diffracted to 2.1 Å was 
obtained in 28% PEG 2000 monomethyl ether, 0.1 M Bis-Tris pH 6.5 (condition 46 of the 
Index HTI screen from Hampton) (Fig. 5.5B).  
 
5.2.2.3 Actin-related functions of zebrafish scinderin-like genes 
 The quality of the purified scinlA and scinlB was assessed through various in vitro 













Figure 5.4 Sequence alignment of zebrafish scinderin-like proteins with human gelsolin and 
adseverin. The sequences were aligned with the ClustalW 2.0.12 and residues are colored 
according to the standard clustalW format. The six domains, demarcated by the color-coded lines 
above them (1 – red, 2 – light green, 3 – yellow, 4 – pink, 5 – dark green, 6 – orange), are based 
on the sequence alignment presented in Choe et al., 2002. Conserved aspartates from the type-I 
calcium-binding sites are highlighted in blue. Conserved aspartate and glutamate residues from 
the type-II calcium-binding site are highlighted in grey. In the domain 3 type-II site (black 
arrowhead), Asp-303 of gelsolin is substituted by Glu-274 in scinlB and Glu-281 in adseverin. 
ScinlB histidines that are not conserved with scinlA or gelsolin are highlighted in yellow. 
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functional assays (Chapter 2, Section 2.2.5). When added to F-actin at a molar ratio of 1:2 in 
the presence of calcium, both scinlA and scinlB efficiently depolymerized actin filaments as 
evidenced by the reduction of fluorescence intensity at a rate comparable to that of gelsolin. 
In the absence of calcium, no decrease in fluorescence is observed suggesting that both scinlA 
and scinlB are calcium-dependent actin-severing proteins (Fig. 5.6A). At the same molar ratio 
of 1:2 to actin, in the presence of EGTA, at pH 6.5, scinlB has intermediate levels of activity 
that results in the slow decrease of fluorescence intensity (Fig. 5.6D). Under these conditions, 
scinlA and gelsolin have minimal activity. Both scinlA and scinlB nucleate actin filament 
formation when mixed with G-actin at a molar ratio of 1:100 (Fig. 5.6B). At higher 
concentrations (molar ratio 1:2 with actin), scinlA and scinlB sequester G-actin and prevent 
polymerization (Fig. 5.6C).  
 
5.1.1.1 Structural data for scinlB 
The scinlB crystal was cut into small pieces and soaked in precipitant solution before being 
picked up in nylon cryoloops (Hampton Research) and flash frozen in liquid nitrogen. ScinlB  
Figure 5.5. Protein preparation and crystallization – scinlA and scinlB (A) SDS-PAGE 
showing the Bio-rad broad range marker (lane 1), purified scinlA and scinlB (lanes 2 and 
3, respectively). (B) Crystal of scinlB obtained in 28% PEG 2000 monomethyl ether, 0.1 
M Bis-Tris, pH 6.5. 
 















Figure 5.6. Biochemical analyses of zebrafish scinderin-like proteins. (A) Actin 
depolymerization assay. ScinlA, scinlB and gelsolin (2 µM) were added to F-actin (4 
µM) in the presence of calcium or EGTA and change in fluorescence intensity measured 
as a function of time. (B) Actin nucleation assay. ScinlA and scinlB were incubated with 
G-actin (4 µM) at molar ratio of 1:100 for 10 minutes in the presence of calcium before 
inducing polymerization. (C) G-actin sequestration assay. ScinlA and scinlB were 
incubated with G-actin (4 µM) at molar ratio of 1:2 for 30 minutes in the presence of 
calcium before inducing polymerization. (D) pH activation assay. ScinlA and scinlB 
were added to F-actin (4 µM) at molar ratios of 1:2 at pH 6.5 in the absence of calcium. 
Gelsolin was added to F-actin (4 µM) at molar ratios of 1:2 at pH 6.5 and 7.5. Change in 
fluorescence intensity measured as a function of time. 
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crystallized in the P212121 spacegroup and there was one molecule in the asymmetric unit. 
The structure of scinlB was solved by molecular replacement using the individual domains of 
inactive human gelsolin as templates in PHASER. Iterative model building and refinement 
resulted in the current model of scinlB (see Chapter 2, Section 2.2.8.3 for detailed protocol). 
The data collection, crystal and refinement statistics are presented in Table 5.1. 
 
5.1.1.2 Structure of inactive scinlB 
In the absence of calcium, scinlB adopts a compact globular conformation 
reminiscent of the inactive structure of gelsolin, as anticipated from the high sequence 
homology. Domain 6 (SB6) is positioned at the core of the protein and functions as a 
linchpin, making contacts with the other domains (SB1 – SB5) arranged around it, with the 
exception of SB4 (Fig. 5.7A). The six domains of scinlB, as demarcated based on the 









Figure 5.7. Structure of scinlB. (A) Schematic representation of the current model of 
scinlB. The six domains are colored as follows: SB1 (salmon), SB2 (pale green), SB3 
(limon), SB4 (magenta), SB5 (green cyan), SB6 (olive). The missing regions of the SB1-
SB2 and SB3-SB4 linkers are highlighted by orange circles. (B) Schematic representation 
of calcium-free human gelsolin PDB ID 3FFN. The domains are colored in accordance 
with Burtnick et al., 1997. The C-terminal helical tail latch that is missing in the scinlB 
structure and the helix formed by the longer G5-G6 linker are highlighted in blue. 





Table 5.1 Data collection and refinement statistics for Scinderin-like B (ScinlB) 
Statistics ScinlB 
Wavelength, Å 1 
Space group P212121 
a, Å 69.5 
b, Å 69.2 
c, Å 77.5 
α, ° 90.0 
β, ° 106.5 
γ, ° 90.0 
Resolution range, Å 19.8 – 2.1 
Unique reflections 38327 (3584) 
Completeness, % 98.3 (87.0) 
Average I/Io 28.5 (2.3) 
Rmerge, % 4.4 (40.5) 
Rfactor, % 20.5 (24.5) 
Rfree, % 27.5 (34.7) 
Molecules in the asymmetric unit 1 
Residue range 5-120, 131-343, 360-709 
Non-hydrogen atoms (waters) 5424 (167) 
Mean derived B-factor (waters), Å2 54.42 (48.23) 
rmsd bonds, Å 0.008 
rmsd angles, ° 1.35 
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SB3 (Gly-242 to Ser-338), SB4 (Lys-388 to Lys-484), SB5 (Thr-507 to Gly-590) and SB6 
(Ala-608 to His-701). 
Despite the similar domain architectures of scinlB and gelsolin, superimposition of 
the structures reveals several differences that translate into a rms distance of 2.5 Å over 621 
Cα equivalences. Many of these variations are localized within the linker and loop regions of 
the structure (Fig. 5.7B). Parts of the loop connecting the A′ and A strands of SB2 (residues 
121-130) and the SB3-SB4 linker (residues 344-359) lacked electron density and are 
therefore, missing from the scinlB structure. However, the most notable difference between 
the two structures is the absence of the predicted C-terminal tail-latch of scinlB.  Inspection of 
the structures of the analogous halves of the two proteins reveals other interesting deviations 
between the two structures. 
The two halves of scinlB (SB1-SB3 and SB4-SB6) adopt L-shaped pseudosymmetric 
structures wherein SB1 and SB4 are juxtaposed with SB3 and SB6, respectively, such that 
their β-strands align to form continuous ten-stranded β-sheets. The long helices of SB3 and 
SB6 are kinked so as to accommodate the neighboring long helices of SB1 and SB4, 
respectively (Figs. 5.8A and 5.8C). In contrast to the full-length proteins, SB1-SB3 is 
relatively similar to G1-G3 (308 Cα equivalences with a rms distance of 1.46 Å) (Fig. 5.8A). 
However, the short helix of SB3 is displaced towards SB2 while the long helix and the E 
strand of SB2 are displaced towards SB3 (Fig. 5.8B). The complete SB2-SB3 linker is present 
in the scinlB structure and appears to adopt a different conformation to the partial G2-G3 
linker visible in the structure of gelsolin. The structures of the C-terminal halves of gelsolin 
and scinlB exhibit similarity comparable to that of the N-terminal halves (316 Cα 
equivalences with a rms distance of 1.46 Å) (Fig. 5.8C). The G5-G6 linker contains a four-
residue insertion as compared to the SB5-SB6 linker and is visibly longer (Fig. 5.8D). 
Structural differences between the corresponding domains of gelsolin and scinlB, especially 
domains 3 and 6 are evident and prompted further analyses. 
 















Figure 5.8. Comparative analysis of the analogous halves of scinlB and gelsolin. Color 
coding for the structures is continued from Fig. 5.7. (A) SB1-SB3 and G1-G3 are 
superimposed based on the G1-G3 β-sheet. The region of variation between structures 
of SB3 and G3 is encircled in blue. (B) An alternative view of A displays variations 
between the scinlB and gelsolin structures. The shifts in the positions of the SB3 short 
helix and SB2 long helix are marked by black arrows. The SB2-SB3 and G2-G3 linkers 
are labeled. (C) SB4-SB6 and G4-G6 are superimposed based on the G4-G6 b-sheet. 
Region of variation between SB6 and G6 is encircled in blue. A small shift in the long 
helix is marked by a black arrow. (D) An alternative view of C reveals that differences 
in the C-terminal half are mostly present in the linker regions. The SB5-SB5 and G5-G6 
linkers are labeled and the single-turn helix formed by the longer G5-G6 linker 
encircled in blue.  
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5.1.1.3 Comparative study of the scinlB domains 
Comparison of the scinlB domains (Fig. 5.9A) suggests that SB1 is most similar to 
SB4 and SB3 to SB6. SB2 and SB5 appear most similar when the A' strand and A'-A loop are 
included within the domain structure. Comparison of the structures with SUPERPOSE from 
the CCP4 suite reveals that indeed SB1 is most closely related to SB4 (92 Cα equivalences 
with rms distance of 1.24 Å) and SB3 is most closely related to SB6 (93 Cα equivalences 
with rms distance of 1.67 Å). Contrary to expectation however, structural superimposition 
suggested that SB2 is more closely related to SB4 (80 Cα equivalences with rms distance of 
1.45 Å) than SB5 (83 Cα equivalences with rms distance of 2.0 Å). Since this varies from the 
domain similarities reported for gelsolin where G1, G2 and G3 are most similar to G, G5 and 
G6, respectively (Burtnick et al., 1997), the primary sequences of the scinlB domains were 
compared. Sequence analysis revealed that SB1, SB2 and SB3 are most closely related to SB4 
(40% identity), SB5 (26% identity), and SB6 (21% identity), respectively (Fig. 5.9B). To 
determine if the inclusion of the A'-A loop and A' strands of G2 and G5 in the comparison of 
the gelsolin domains was responsible for this difference, SB2 including the A'-A loop and A' 
strand (residues 109-219) was compared with SB4 and the SB5 including the A'-A loop and 
A' strand (residues 486-590). No effect on the similarity of SB2 to SB4 was observed while 
the similarity between SB2 and SB5 improved (89 Cα equivalences with rms distance of 1.8 
Å), despite the missing residues in the SB2 A'-A loop. It is likely that if the missing residues 
of SB2 were present, SB2 and SB5 would display a significantly greater similarity, as in the 
case of G2 and G5. Hence, it is possible that scinlB and gelsolin share a common 
evolutionary history that predates the separation of the zebrafish scinderin-like proteins from 
the classical vertebrate scinderin and gelsolin clusters described by Jia et al. (2007).  
 
5.1.1.4 Comparative analysis of individual domains of scinlB and gelsolin 
As expected from the sequence conservation between scinlB and gelsolin, their 
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corresponding domains display very similar structures (Table 5.2). To identify variations, the 
analogous domains of the two proteins were superimposed based on the long helix. Several 
intriguing differences between scinlB and gelsolin were revealed. In comparison with G1, the 
SB1 C and D strands and CD-loop are significantly shorter than the corresponding regions of 
G1 (Figs. 5.10A and 5.10B). This shortening of the CD loop is caused by a four-residue 
deletion in the SB sequence that corresponds to gelsolinresidues 76-79 (Fig. 5.4). 
Interestingly, no other large variation between SB1 and G1, in either the active or inactive 
conformation, is apparent.  
SB2 however, is more similar to inactive G2 than active G2 (Figs. 5.10C and 5.10D). 
A small displacement of the short helix of SB2 compared with inactive G2 that was 
previously described (Fig. 5.8) is apparent. While, the loss of the A' strand is one of the key 
differences between SB2 and active G2, there is also variation in the position of the AB loops 
and β-sheet. This change in the conformation of the AB loop of active G2 is possibly linked 
to the rearrangement of the A'-A loop and A' strand to permit the extension of the G1-G2 
linker during activation.  
The most conspicuous feature of SB3 when compared to the other domains is the kink 
in the long helix. When the long helices of SB3 and G3 are overlaid, both the β-sheet and 
 
Table 5.2 Structural variations between scinlB and gelsolin domains 
ScinlB Gelsolin domain 
 Inactive  Active 
RMSD 
Å 
Cα equivalences RMSD 
Å 
Cα equivalences 
SB1 G1  0.99 102  0.94 102 
SB2 G2  1.00 103  1.32 91 
SB3 G3  1.02 100  1.50 98 
SB4 G4  1.22 96  1.15 93 
SB5 G5  0.84 104  0.97 99 
SB6 G6  1.10 90  1.40 93 
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short helix of SB3 are displaced (Fig. 5.10E). More strikingly, the AB loop is bent away from 
the long helix in sharp contrast with the corresponding loop of inactive G3. SB3 also differs 
from active G3 in having a bent long helix. The AB loop also adopts different conformations 
in SB3 and active G3 such that the conformation of SB3 appears to be intermediate between 
those of inactive and active G3.  
The C and D strands of SB4 display a significantly different conformation to both 
inactive and active G4 (Figs. 5.10G and 5.10H). The SB4 β-sheet and short helix appear to be 
displaced in opposite directions when compared with inactive and active G4, suggesting that 
SB4 may be in an intermediate state. The structure of SB5 differs from that of G5 primarily at 
the loop regions except for a small displacement of the short helix (Fig. 5.10I). Activation of 
G5 results in the alteration of the position of the A′-A loop, due to the formation of a calcium-
coordination site at the G4-G5 interface. This altered conformation results in the only 
prominent difference between SB5 and active G5 (Fig. 5.10J). 
Like SB3, inactive SB6 is characterized by the kinked long helix. Comparison of SB6 
with inactive G6 reveals a marked transposition of the β-sheet and short helix (Fig. 5.10K). 
Notably, the SB6 A and B strands and AB loop are in the same conformation as activated G6 
although the SB6 long helix is bent like the inactive G6 long helix (Figs. 5.10K and 5.10L). 
 
5.1.1.5 Towards the structure of scinlB/actin   
ScinlA/actin and scinlB/actin complexes formed and purified as described in Section 
2.2.6 were analyzed by SDS-PAGE (Figs. 5.11A and 5.11C). ScinlA-actin at 4.5 mg/ml and 




ScinlB may be partially active 
ScinlB is an intriguing protein that is phylogenetically slightly closer to human 

























adseverin and yet has characteristics unique to gelsolin, such as the extra C-terminal residues 
that could fold into a tail latch. The domain architecture of calcium-free scinlB is identical to 
that of calcium-free gelsolin. Yet there are several localized variations in the structures, 
particularly in the loop and linker regions (Fig. 5.10). These variations prompted biochemical 
analyses to determine the source of variation between the structures. Intriguingly, while 
Figure 5.11. Towards the structure of scinlA/actin and scinlB/actin complexes. (A) and (B) 
Chromatograms for the preparation of scinlA/actin and scinlB/actin complexes, 
respectively, by gel filtration on a HiLoad 16/60 Superdex 200 column (GE Healthcare). 
Two protein peaks are observed (blue line represents absorbance at 280 nm) for each run. 
(C) SDS-PAGE analysis of the eluted proteins from (A) and (B). The first peak in both (A) 
and (B) contains excess F-actin. The second peak contains the complex of interest. 
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scinlB demonstrates efficient calcium-dependent actin monomer sequestration, filament 
depolymerization and nucleation activity similar to gelsolin (Figs. 5.6A and 5.6C), it also 
exhibits significantly greater pH sensitivity in actin filament depolymerization (Fig. 5.6D). 
That scinlB activity at pH 6.5 is lower than in calcium, suggests that scinlB is partially active 
in these conditions. Results of the biochemical analyses reveal that the condition in which 
scinlB was crystallized (28% PEG 2000 monomethyl ether, 0.1 M Bis-Tris, pH 6.5) is semi 
activating (Fig. 5.6D).    
A closer look at the structure of scinlB reveals several structural characteristics that 
are associated with the activation of gelsolin. The putative C-terminal tail of scinlB, the 
release of which by analogy to the gelsolin tail is a critical step in the activation of scinlB, is 
absent from this structure, suggesting that this region of the protein is disordered (Fig. 5.7). 
Since, the straightening of the A and B strands and AB loops of domains 3 and 6 are 
associated with the activation of gelsolin (discussed in Chapter 3), the straight A and B 
strands and AB loop of SB6 appear to be in the active conformation (Fig. 5.10J). Similarly, 
the SB3 AB loop appears to be in a conformation that is intermediate between the inactive 
and the active (Figs. 5.10C and 5.10D). Further differences between the calcium-free 
structures of scinlB and gelsolin exist in the conformations of domain 4 (Figs. 5.10E and 
5.10F) and the linker connecting domains 2 and 3 (Fig. 5.8B). Together these variations 
indicate that despite the absence of any detectable calcium ions in the structure presented, 
scinlB is partially active. 
 In contrast, scinlB has the overall globular structure characteristic of inactive gelsolin 
and two of the three latches that are believed to hold the inactive conformation together, the 
SB1-SB3 and the SB4-SB6 latches are intact. Furthermore, the long helices of SB3 and SB6, 
the straightening of which has been proposed to have an important role in activation 
(discussed in Chapter 3), are bent as in the case of calcium-free gelsolin suggesting that 
scinlB is not completely activated.  
Homology modeling of the inactive structure of scinlB in SWISS-MODEL (Fig. 
5.12) yields a model of scinlB (SB_model) that is nearly identical to the structure of inactive 
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gelsolin (713 Cα equivalences with rms distance of 0.94 Å) in contrast with the scinlB 
structure presented here (670 Cα equivalences with rms distance of 3.82 Å) as determined by 
superimposition with SUPERPOSE. Within SB_model the 12 C-terminal residues that are 
disordered in the scinlB structure, fold into a tail helix that interacts with SB2, and the A and 
B strands and AB loops of both SB3 and SB6 are in the inactive conformation. This implies 
that the variation in the structures of calcium-free scinlB and gelsolin may not be due to 
sequence variations between the two proteins. It therefore seems possible that in the structure 
presented here scinlB may have been trapped in one of the early activation stages. Hence, in 
the following sections, the differences between calcium-free scinlB and calcium-free gelsolin 














Straightening of the domain 6 AB loop has a significant role in activation 
The structural differences between inactive gelsolin and partially activated scinlB 
offer clues about the activation process. In the scinlB structure, two steps of the activation 
process, namely the release of the tail and the straightening of the SB6 AB loop have been 
Figure 5.12. Model of inactive calcium-free scinlB created by homology modeling with 
SWISS-MODEL (http://swissmodel.expasy.org/). Regions that are missing from the 
experimentally determined structure of scinlB (Fig. 5.7A) are encircled in orange. 
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completed whereas the conformation of the SB3 AB loop is intermediate between the inactive 
and active forms (Fig. 5.10) suggesting that the first two steps precede the latter during 
activation. The straightening of the SB6 AB loop appears to be linked to the displacement of 
the SB2-SB3 linker (Fig. 5.13B) that connects directly to the A strand of SB3 (Fig. 5.8B). It is 
possible therefore, that information about activation travels from SB6 to SB3 through the 
displacement of the SB2-SB3 linker, which could result in the straightening of the SB3 AB 
loop.  
Close inspection of the calcium-free structure of gelsolin revealed a network of 
interactions between residues from G2 and G6 that participate in the stabilization of this 
conformation (Fig. 3.7). Examination of the scinlB structure reveals that the corresponding 
residues of scinlB (Asn-177, Glu-180, Arg-139 and Arg-140 from SB2 and Asp-637 and Asp-
638 from SB6) are in close proximity, but the interactions are slightly altered due to the 
presence of Lys-616 from the straight SB6 AB loop (Fig. 5.13C). It appears that the 
straightening of the SB6 AB loop repositions Lys-616, which then pushes away Asn-177 and 
along with it the long helix of SB2, consequently weakening the interactions that are evident 
in calcium-free gelsolin (Fig. 5.13C). Should this chain of events occur during calcium 
activation, it would make Glu-180 (conserved with G2 calcium-coordinating residue Glu-209) 
available for calcium-coordination, thus explaining the mechanism behind the cooperativity 
of calcium binding by domains 2 and 6 (Chapters 3 and 4). To determine if this mechanism 
may be employed in the course of gelsolin activation, the structure of active G6 was 
superimposed on G6 of calcium-free gelsolin (Fig. 5.13D). Indeed, Lys-648 (conserved with 
ScinlB Lys-616) from the straight AB loop of active G6 clashes with Asn-206 (conserved 
with ScinlB Asn-177) of inactive G2 indicating that this mechanism may be employed by 
gelsolin (Fig. 5.13D). 
Thus the domain 6 AB loop appears to have an important role in the activation of 
both gelsolin and scinlB. Straightening of this loop may effect activation in two possible 
ways; first, by transferring information about activation to the N-terminal half of the protein 
through changes in the conformation of the domain 2 – domain 3 linker and secondly, by  














disrupting the network of domain 2 – domain 6 interactions that stabilize the inactive 
conformation. While both gelsolin and scinlB may be activated through parallel mechanisms 
and involve the collaboration of many minute conformational changes, the mechanism by 
Figure 5.13. Cooperative activation by domains 2 and 6 of scinlB and gelsolin. (A) 
Structure of scinlB in an orientation that displays the SB2-SB6 interface. (B) Comparison of 
the positions of SB6 (olive) and G6 (wheat) AB loops and SB2-SB3 linker (dark green) and 
G2-G3 linker (light green). (C) A closer look at the interactions between SB2 and SB6. The 
residues homologous to those involved in stabilizing inactive gelsolin (Fig. 3.7) are 
displayed in dark grey. Lys-616 from the SB6 AB loop disrupts the interactions between 
Asn-177 and Arg-139, causing the repositioning of the SB2 helix. Asn-206 (light grey) from 
G2 (light green), which is homologous to Asn-177, is displayed to compare the positions of 
these residues in the presence and absence of Lys-616. (D) The G2-G6 interface in a 
conformation identical to SB2-SB6 in (C) is displayed. Active G6 (grey) is superimposed 
upon in active G6 to demonstrate how Lys-648 from the active AB loop clashes with Asn-
206 from G2. 
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which these small changes are translated into the large domain rearrangements necessary for 
complete activation remain unclear. It is hoped that, in the future, structures of scinlB/actin or 
scinlA/actin can be resolved to further elucidate these mechanisms. 
 
Calcium and pH activation – two sides of the same coin 
The lack of bound calcium ions in the scinlB structure, suggests that the structural  
changes signifying activation that are observed may be caused by the low pH (6.5) at which 
scinlB was crystallized. That scinlB is partially activated at this pH has been demonstrated 
(Fig. 5.6D). Comparison of the structures of calcium-free scinlB with calcium-free and 
calcium-bound structures of gelsolin (Figs. 5.10 and 5.13) suggests that pH activation and 
calcium-activation share some common mechanisms contrary to previous reports that suggest 
that low pH induces structural changes different from those induced by calcium-binding 
(Lagarrigue et al., 2003b). For example, in the scinlB structure, the C-terminal tail-latch is 
released, the bonds between domains 2 and 6 are weakened, and the AB loops of domains 3 
and 6 are straightened, albeit to different degrees, all of which are structural changes 
associated with calcium-activation.  
Interestingly, although gelsolin has been reported to exhibit pH-dependent activation 
that is associated with an increase in hydrodynamic radius, similar to calcium-dependent 
activation (Lamb et al., 1993), both gelsolin and scinlA exhibit low levels of activity 
compared to scinlB at pH 6.5 (Fig. 5.6D). In an attempt to understand this finding, the 
sequences of these proteins were inspected for the presence of histidines that may participate 
in the pH-induced activation of scinlB. ScinlB has a total of 15 histidines, four of which are 
absent in all the other sequences compared (scinlA, gelsolin, and adseverin) (Fig. 5.4). These 
are located in the SB1-SB2 linker (His-121, His-129), SB4 (His-474) and SB6-C-terminal tail 
hinge (His-701). A fifth residue (His-47) located in SB1 is conserved in adseverin but absent 
in scinlA and gelsolin. In the absence of a completely inactive structure of scinlB, it is 
difficult to determine the contributions of these residues to the activation process. Sequential 
mutagenesis of the five scinlB-specific histidines may shed some light on their roles in the 
Chapter 5. Insights from Adseverin and scinderin-like B 
 116 
pH-dependent activation of scinlB. However, the location of His-701 at the junction of SB6 
and the C-terminal extension makes it an attractive candidate for further analysis. 
 
The C-terminal halves of gelsolin and adseverin contain analogous functional motifs 
A4-A6 and G4-G6 display identical monomer sequestering activity that is abolished 
by analogous single mutations within domain 4 (Fig. 5.3), thus establishing the long helix of 
domain 4 as the primary actin-binding site within the C-terminus of both adseverin and 
gelsolin. The inability of A5-A6 and G5-G6 to nucleate filaments, in conditions ideal for 
efficient nucleation by full-length adseverin and gelsolin, contradicts previous literature 
(Lejen et al., 2002; Marcu et al., 1998) but is commensurate with the structure of A4-A6. In 
this structure, the reported actin-binding site (residues 511-523) is buried within the A5 β-
sheet and cannot be accessed by actin (Fig. 5.2). The modest dampening of actin 
polymerization in the presence of A5-A6 or G5-G6 at low ratios to actin (1:100) (Fig. 5.3D) 
is probably caused by basal-level sequestration of actin monomers by the minor actin-binding 
site located on domain 6 (Fig. 5.2) and agrees with similar reduction in fluorescence intensity 
observed during the monomer sequestration assay (Fig. 5.3B). The analogous functional 
behavior, demonstrated by the C-terminal halves of gelsolin and adseverin, highlights the 
similar mechanisms and conserved residues responsible for the actin binding function and 
offers the means to predict similar activities within other gelsolin family proteins. Phe-452 
within the scinlB sequence is analogous to the conserved Phe-455 and Ile-481 of adseverin 
and gelsolin, respectively (Fig. 5.4), and is nestled amidst a stretch of conserved residues that 
comprise the SB4 long helix. The structure of scinlB is highly homologous to that of gelsolin. 
Therefore, it is likely that the scinlB C-terminal half binds actin through the conserved site on 
SB4 in a manner analogous to gelsolin and adseverin.  
 
Calcium-regulatory mechanisms of gelsolin and adseverin  
Adseverin and gelsolin display distinct differences in calcium-sensitivity that have 
been attributed to the presence of the C-terminal tail of gelsolin (Lin et al., 2000; Lueck et al., 
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2000). Titration of the F-actin depolymerization activity of the two halves of adseverin, full-
length adseverin and full-length gelsolin against a calcium gradient demonstrates that 
adseverin activity is regulated by the binding of calcium to the N-terminal half of the protein 
(Fig. 5.3C). This differs from the regulation of full-length gelsolin activity, which is 
distributed between both halves with the possibility that the contribution of the C-terminal 
half is greater (discussed in Chapters 3 and 4). The calcium-requirement for function of the N-
terminal half of adseverin is significantly lower than that of the C-terminal half, which is also 
the trend displayed by the gelsolin halves. However, A1-A3 retains a requirement for calcium 
to be activated whereas G1-G3 can function in the absence of calcium. Thus far, the actin-
related functions of scinlA and scinlB have not been analyzed in detail. Experiments 
conducted in the current study demonstrate that full-length scinlA and scinlB sever and 
nucleate filaments and sequester actin monomers in a calcium-dependent manner (Figs. 5.6A 
and 5.6C). Analysis of the activities of the independent halves may provide interesting 
insights into the calcium-regulation of these proteins. 
 
Implications for actin severing    
In the model of filament severing presented in Chapter 1 (Fig. 1.12), the considerable 
clashes of the extended CD strand of G1 with protomer I, play an important role in filament 
severing. While functional assays demonstrated that scinlB sequesters and probably severs 
actin (Figs. 5.6A and 5.6C), the CD loop of SB1 is significantly shorter than that of G1 (Fig. 
5.10A). Overlaying the SB1 structure upon the G1/F-actin model reveals that clashes between 
the SB1 CD loop and protomer I are substantial although not as extensive as G1 (Fig. 5.14A), 
thus supporting the presented model. 
In the structure presented here, despite the lack of the C-terminal tail and other 
localized differences, scinlB displays an overall globular structure that, like inactive gelsolin, 
should be unable to bind actin (Fig. 5.14B). However, scinlB was crystallized at pH 6.5, a 
condition in which, scinlB depolymerizes actin almost to the same extent as in the presence of 
calcium at pH 7.5, although at a much slower rate (Fig. 5.6D). This is reminiscent of the six-  









site mutants of gelsolin that, in EGTA, depolymerize F-actin to the same extent as but much 
slower than wild-type gelsolin does in calcium (Fig. 4.8A). The activity of these mutants was 
shown to be due to the release of their tail-latches that permitted them to dynamically open 
and close, thus allowing actin to access the binding sites on the protein (Fig. 4.9). It is 
therefore likely that the activity of scinlB at low pH is due to the release of the tail-latch that 
permits it to dynamically transition between the closed conformation, where the actin-binding 
sites are inaccessible, and open conformations that are competent to bind actin. 
 
Figure 5.14. Actin severing by scinlB. (A) SB1 superimposed upon G1 docked on F-actin from 
Fig. 1.12. Clashes between SB1 and protomer-I are evident. (B) ScinlB is docked on F-actin by 
superimposition on G2 docked on F-actin from Fig. 1.12. Clashes of SB6 and SB4 with actin 
should prevent binding of SB2 to F-actin in this conformation. Regions of clash between SB6 
and actin are encircled in red and those between SB2 and actin are encircled in blue. 
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Chapter 6. Perspectives and Conclusions 
6.1 Matters arising – insights and questions 
It is often the case that the search for the answer to one question, not only yields some 
understanding of the subject under study, but also raises new questions and issues that require 
further discussion and exploration. This section is devoted to the insights provided within this 
thesis, their implications, questions that have arisen from them, and those that remain 
unanswered. 
 
The activation of gelsolin  
Gelsolin activity has a stringent requirement for calcium, being completely abolished 
by its removal (Bryan and Coluccio, 1985; Janmey et al., 1985; Yin and Stossel, 1980). 
However, the isolated gelsolin N-terminal half severs actin in a calcium-independent manner 
as opposed to the isolated C-terminal half, which retains the essential requirement for 
micromolar levels of calcium in order to bind actin (Bryan, 1988; Chaponnier et al., 1986; 
Kwiatkowski et al., 1985). Calcium activates gelsolin by inducing conformational changes in 
the C-terminal half including the release of the C-terminal tail-latch, that exposes the actin-
binding site on G2 (Burtnick et al., 1997; Kwiatkowski et al., 1989; Patkowski et al., 1990). 
In conjunction, these data have led to the general conviction that the calcium-regulation of 
gelsolin resides within the C-terminal half of the protein. Mutational analysis of gelsolin 
conducted in the course of this study demonstrates that the release of the tail-latch is in fact a 
critical step in the activation of gelsolin (Figs. 4.2 and 4.9), although the exact calcium 
concentration at which this event occurs has not been explored. Due to its proximity to the tail 
helix (Burtnick et al., 1997) and its high affinity for calcium (Kd=0.2 µM, Pope et al., 1995), 
the G6 calcium-binding site has been suggested to be responsible for tail-latch release. 
However, close inspection of the interface between domains 2 and 6 of calcium-free gelsolin 
and calcium-free scinlB reveals that these two domains maintain the inactive structure 
through inter-domain interactions that involve the very residues that bind calcium during 
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activation (Nag et al., 2009, also see Figs. 3.7 and 5.13). Furthermore, mutational analyses 
provide evidence of the cooperativity of G2 and G6 (Fig. 4.3). In addition, the scinlB 
structure, which appears to be trapped in a partially activated conformation, suggests a 
possible mechanism underlying the cooperative binding of calcium by these two domains. 
The straightening of the domain 6 AB loop results in the repositioning of a conserved residue 
(Lys-616 of scinlB and Lys-648 of gelsolin) so that interactions between domains 2 and 6 that 
stabilize the inactive conformation are disrupted and the conserved calcium-binding residues 
are freed for coordinating calcium (Figs. 3.7 and 5.13). Thus, despite the calcium-independent 
activity of the N-terminal half of gelsolin, when isolated from the C-terminal half, it is 
apparent that the activation of full-length gelsolin requires the cooperative action of both 
halves.  
Although G2 and G6 participate in tail-latch release, activating mutations within these 
sites alone are insufficient to elicit this conformational change (Figs. 4.3 and 4.9). Whether 
this is due to a true requirement for a third calcium-binding event or the consequence of the 
inadequate effect of the substituted asparagines as compared to calcium coordination, remains 
unclear. Nonetheless, it is evident that three calcium-binding events in either domains 2, 4 and 
6 or 2, 5 and 6 is sufficient, not only for the release of the tail-latch but also additional 
conformational changes leading to greater activity than can be explained by the mere release 
of the tail-latch (Figs. 4.8 and 4.9). Possible mechanisms through which calcium binding to 
these specific sites elicits the release of the tail-latch, and the subsequent conformational 
changes, are proffered based on clues from the comparative study of the active and inactive 
structures of the C-terminal half of gelsolin (Figs. 4.11 and 4.12). It is possible that calcium 
binding to G4 and G5, elicit small changes in the conformation of these domains that 
cooperate to allow the actin-binding site on the G4 long helix to become accessible without 
releasing the tail-latch. In combination with calcium-binding events at G2 and G6, not only is 
the tail-latch released but additional rearrangements, resulting in significantly higher activity, 
also become possible (Figs. 4.5 and 4.8). Although the exact mechanism through which these 
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four domains, G2, G4, G5 and G6, operate requires further elucidation, it is evident that they 
participate in the activation of gelsolin. 
While the role of the G1 type-II site requires further study, the lack of significant 
effect of the mutation at this site on gelsolin activity, beyond what could be attributed to basal 
level cooperation due to the destabilization effect of the mutation, is unsurprising. It is known 
that G1 in isolation binds actin in a calcium-independent manner (Pope et al., 1991) and the 
structures of inactive and active G1 display little variation (Fig. 5.10). Furthermore, G1 has 
been shown to contain a calcium-binding site, the affinity of which is altered by the presence 
of actin (Weeds et al., 1995). It is therefore, possible, that a mutation within this site has little 
effect upon the structure of G1 and consequently on the structure of full-length gelsolin. In 
contrast, the role of G3 is baffling. Structural evidence suggests that binding of calcium to the 
G3 site results in the straightening of the long helix, A and B strands and the AB loop, all of 
which are changes associated with the activation of gelsolin (Figs. 3.5 and 3.8). Conversely, 
the substitution of the conserved aspartate of the G3 calcium-binding site to an asparagine, 
unlike all the other domains, appears to diminish the activity of the mutant (Fig. 4.5). 
Undoubtedly, this paradox merits further examination. Another key aspect of the activation 
process has remained elusive. That any three mutations, within the calcium-binding sites of 
gelsolin, result in some activation is a testament to their cooperation (Fig. 4.5). However this 
cooperativity has precluded the definition of the order in which calcium-binding events occur 
during the activation of gelsolin. This understanding is necessary to the delineation of the 
mechanistic details of the activation process and demands further examination. 
 
The importance of disorder – roles of loops and linkers 
Previous structural studies on gelsolin have clearly demonstrated that activation of 
gelsolin involves changes in linker regions that reposition the domains without significantly 
altering the core domain structures (Figs. 1.10 and 1.11; Burtnick et al., 1997; Burtnick et al., 
2004; Robinson et al., 1999). Besides gelsolin, scinlB is the only other member of the gelsolin 
family whose full-length structure has been solved. The domain organization of these two 
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proteins is similar (Fig. 5.7) and the structures of individual domains nearly identical (Table 
5.2, Fig. 5.10). However, superimposition yields a high r.m.s. distance of 2.5 Å over 621 Cα 
equivalences, suggesting that the major variations in these structures are localized within the 
loop and linker regions. The biochemical assay of scinlB and clues gathered from the 
differences between the scinlB and calcium-free gelsolin structure suggest that scinlB may be 
partially activated. If this is indeed true, then the variations in the loop and linker regions of 
the two structures further emphasize their importance in the activation process. In case of 
villin, the linker between domain 6 and the headpiece forms a hinge that plays a key role in 
activation (Hesterberg and Weber, 1983). It is also established that the linker regions contain 
functional motifs. For example, the G1-G2 linker plays a crucial role in filament severing and 
variations within this sequence abrogate severing activity in capG (Irobi et al., 2003; 
Kwiatkowski et al., 1989; Southwick, 1995; Zhang et al., 2006). In conjunction, these data 
strongly emphasize the pivotal role of the inter-domain regions in the activation and function 
of the gelsolin family proteins. 
 
The C-terminal tail – functions, implications, raison d’être 
The importance of the C-terminal tail in the maintenance of gelsolin inactivity in the 
absence of calcium has been proven beyond doubt (Kwiatkowski et al., 1989; Lin et al., 
2000). Apart from confirming that gelsolin has partial activity in EGTA when the tail is 
removed, the biochemical analyses conducted in the course of this study demonstrate the 
mechanism through which tail-less gelsolin is activated in the absence of calcium (Chapter 4). 
Without the multiple interactions between the tail and the G2 helix, the two halves of the 
protein are free to move independently of each other so that the protein dynamically opens 
and closes. In the open conformation, one or more actin-binding sites, possibly within the 
calcium-independent N-terminal half, are accessible such that when present, actin can bind 
gelsolin and elicit further conformational changes leading to its calcium-independent 
activation. Yet, despite its crucial role, the C-terminal tail is unique to gelsolin, at least 
amongst the known mammalian proteins of the family. That the activity of tail-less gelsolin is 
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identical to that of full-length gelsolin, when activated by calcium, suggests that the tail is not 
involved in the folding or actin-modulatory functions of gelsolin (Fig. 4.2). Why then has this 
unique structural feature evolved?  
That gelsolin is also the only known member of the gelsolin family that has calcium-
independent severing activity in its N-terminal half, a physiologically relevant fragment with 
an established role in apoptosis, offers a possible answer to this question (Azuma et al., 2000; 
Kothakota et al., 1997). It may be that the requirement for a constitutively active F-actin 
severing protein during apoptosis prompted the evolution of the tail-latch as a means to 
harness the calcium-independent severing activity of the gelsolin N-terminal half until 
appropriate signaling cascades release it through cleavage of full-length gelsolin by caspase-3. 
If indeed this were true, the presence of the C-terminal tail and calcium-independent activity 
of the N-terminal half may be correlated, suggesting that the N-terminal halves of the 
zebrafish scinderin-like proteins, containing putative C-terminal tail latches (Fig. 5.4), may 
exhibit calcium-independent activity similar to gelsolin. 
 
Adseverin – not tail-less gelsolin 
Adseverin has been referred to as tail-less gelsolin in literature because it 
demonstrates high sequence identity, similar domain architecture and a similar distribution of 
functional modules with gelsolin but lacks the C-terminal tail helix (Sakurai et al., 1990). 
While it has been reported that the removal of the gelsolin C-terminal tail abolishes the 
calcium-regulatory differences between gelsolin and adseverin (Lueck et al., 2000), results 
presented within this study provide evidence that although the C-terminal halves of gelsolin 
and adseverin have similar structures and calcium-binding sites (Fig. 5.1), there exist 
differences in the calcium-regulation of adseverin and gelsolin (Fig. 5.3). Adseverin activity 
appears to be regulated predominantly by calcium-binding to the N-terminal half of the 
protein. This is in contrast with gelsolin whose calcium-regulation has been shown to be 
distributed over both halves. Also, unlike the gelsolin N-terminal half, the adseverin N-
terminal half requires calcium for activity, at levels similar to full-length adseverin, prompting 
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the question; what are the sequence or structural differences between adseverin and gelsolin 
that confer calcium-dependence on the N-terminal half of one but not the other?  
While the underlying reason for it remains an enigma, this difference in the activities 
of the N-terminal halves of gelsolin and adseverin may be able to explain how adseverin 
remains inactive in the absence of calcium, despite the absence of the C-terminal tail. It is 
possible that in the absence of the tail, adseverin like tail-less gelsolin can switch between two 
or more conformations. However, since all the actin-binding sites on adseverin are calcium-
dependent, the protein is unable to function without calcium despite the absence of the tail.  
 
Role of G2 in gelsolin activation – implications for familial amyloidosis, Finnish-type 
Familial amyloidosis, Finnish type (FAF) is a hereditary systemic disease 
characterized by the extracellular deposition of a 71-residue fragment of gelsolin that is 
caused by the mutation of the conserved G2 calcium-binding residue Asp187 to Asn or Tyr 
(Maury, 1991). Mutant gelsolin (GFL∆187) is cleaved sequentially by furin in the trans-golgi 
into a 68 kDa fragment, and then by membrane associated type I matrix metalloproteases into 
8- and 5-kDa fragments that form the deposits (Chen et al., 2001; de la Chapelle et al., 1992; 
Maury, 1991; Page et al., 2005). Comparison of the structures of inactive gelsolin and active 
G1-G3 reveals that the furin cleavage site, Arg172-Ala173, is protected in both conformations 
– by G1 in the former and by G3 in the latter (Nag et. al. 2009). It has therefore been 
proposed that GFL∆187 is susceptible to furin cleavage when it is in one of the intermediate 
conformations.  
The results presented in Chapter 4, show that the Asp187Asn mutation has an 
activating effect on gelsolin. It has also been demonstrated that in cooperation with G6, G2 
helps to release the tail-latch, which then allows gelsolin to dynamically open and close. With 
G2 containing a partially activating mutation, lower calcium concentrations may possibly 
release the tail-latch and drive gelsolin into an intermediate conformation where the furin 
cleavage site is exposed. The mutation of Asp187 destabilizes gelsolin due to the loss of 
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calcium-coordination (Kazmirski et al., 2002). While this destabilization, reported as a 
decrease in melting temperature from 60 °C to 43.5 °C, may not be relevant at the 
physiological temperature of 37 °C, results presented in Chapter 3 demonstrate that G2-G3 is 
polydisperse in the absence of calcium even at temperatures as low as 25 °C, indicating that it 
exists in multiple conformations. In the low calcium conditions tested (EGTA or 10 µM 
calcium), the Asp  Asn mutation appears to mimic calcium binding. It is however possible, 
that this mutation provides only partial occupancy, such that in high calcium concentrations 
like those present in the golgi (~ 0.3 mM, Dolman and Tepikin, 2003), GFL∆187 binds 
calcium less efficiently than wild-type gelsolin. In this situation, G2-G3 may exist in dynamic 
equilibrium between several conformations, some of which would be susceptible to furin. 
Thus, it is possible that GFL∆187 is more susceptible to furin because it enters one of the 
intermediate conformations at lower calcium concentrations than wild-type gelsolin, and in 
the absence of calcium binding at G2, remains trapped in dynamic equilibrium between 
various intermediate conformations that are susceptible to cleavage in the trans-golgi. 
 
6.2 Future Work 
While this study has yielded some insights into the regulation and activation of 
gelsolin family proteins, it has also raised questions and opened up avenues for future 
research that can add to this knowledge.   
 
1) Of foremost interest would be the structural characterization of the gelsolin calcium-
binding mutants. Such characterization may define the effect of the specific substitutions on 
the gelsolin structure and explain how they mediate the activation of gelsolin. The range of 
available mutants will possibly allow the elucidation of various intermediate structures of 
gelsolin thus providing in-depth understanding of the mechanism through which each site 
contributes to gelsolin activation and function. X-ray crystal structures that reveal details of 
specific conformations at atomic resolution may be complemented by information about the 
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protein in solution determined through small-angle X-ray scattering (SAXS) and hydrogen-
deuterium exchange (HDX) experiments. 
 
2) While defining the roles and effects of individual calcium-binding sites of gelsolin is 
crucial, the understanding of the activation process of gelsolin would remain incomplete 
unless the order of the calcium-binding events is identified. Previous attempts to identify the 
affinities of the various calcium-bindings sites and connect calcium concentrations to specific 
changes in conformation have yielded controversial data not only because of the inherent 
complexity of gelsolin but also because these studies conducted on fragments of gelsolin have 
disallowed the visualization of the effects of individual sites on the whole protein. The 
numerous calcium-binding mutants of gelsolin, made available by this study, offer an avenue 
for the accurate determination of the affinities of the various sites of gelsolin in the context of 
the whole protein, through calorimetric experiments. 
 
3) Unexpectedly, scinlB has offered the means to elucidate the alternative activation 
pathway mediated by changes in pH. Thus far, gelsolin and adseverin were the only gelsolin 
family proteins known to display pH-mediated activation. In this study, scinlB demonstrates 
considerably greater pH-sensitivity than gelsolin, at pH 6.5 (Fig. 5.5), that may be ascribed to 
the additional histidine residues in its sequence. Site-directed mutagenesis of the implicated 
histidines of scinlB therefore, may help elucidate the mechanism of pH-mediated activation.  
 
 
In conclusion, this study has attempted to gain a better understanding of the activation 
of human gelsolin, human adseverin and zebrafish scinderin-like B, through a combination of 
structural and biochemical analyses. The results presented here have provided fresh insights 
into the regulation and the mechanism of activation of these proteins. Furthermore, they have 
highlighted similarities and differences that, in future, may permit the extrapolation of our 
understanding to the rest of the gelsolin family. This body of work has also laid the 
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groundwork for future research that can further elucidate the activation and function of the 
gelsolin family proteins. It is hoped that such understanding will eventually allow the 
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Abstract 
Gelsolin consists of six homologous domains (G1–G6), each containing a conserved Ca-
binding site. Occupation of a subset of these sites enables gelsolin to sever and cap actin 
filaments in a Ca-dependent manner. Here, we present the structures of Ca-free human 
gelsolin and of Ca-bound human G1–G3 in a complex with actin. These structures closely 
resemble those determined previously for equine gelsolin. However, the G2 Ca-binding site is 
occupied in the human G1–G3/actin structure, whereas it is vacant in the equine version. In-
depth comparison of the Ca-free and Ca-activated, actin-bound human gelsolin structures 
suggests G2 and G6 to be cooperative in binding Ca2+ and responsible for opening the G2–G6 
latch to expose the F-actin-binding site on G2. Mutational analysis of the G2 and G6 Ca-
binding sites demonstrates their interdependence in maintaining the compact structure in the 
absence of calcium. Examination of Ca binding by G2 in human G1–G3/actin reveals that the 
Ca2+ locks the G2–G3 interface. Thermal denaturation studies of G2–G3 indicate that Ca 
binding stabilizes this fragment, driving it into the active conformation. The G2 Ca-binding 
site is mutated in gelsolin from familial amyloidosis (Finnish-type) patients. This disease 
initially proceeds through protease cleavage of G2, ultimately to produce a fragment that 
forms amyloid fibrils. The data presented here support a mechanism whereby the loss of Ca 
binding by G2 prolongs the lifetime of partially activated, intermediate conformations in 
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Abstract 
Adseverin is a member of the calcium-regulated gelsolin superfamily of actin severing and 
capping proteins. Adseverin comprises 6 homologous domains (A1-A6), which share 60% 
identity with the 6 domains from gelsolin (G1-G6). Adseverin is truncated in comparison to 
gelsolin, lacking the C-terminal extension that masks the F-actin binding site in calcium-free 
gelsolin. Biochemical assays have indicated differences in the interaction of the C-terminal 
halves of adseverin and gelsolin with actin. Gelsolin contacts actin through a major site on G4 
and a minor site on G6, whereas adseverin uses a site on A5. Here, we present the X-ray 
structure of the activated C-terminal half of adseverin (A4-A6). This structure is highly 
similar to that of the activated form of the C-terminal half of gelsolin (G4-G6), both in 
arrangement of domains and in the 3 bound calcium ions. Comparative analysis of the actin-
binding surfaces observed in the G4-G6/actin structure suggests that adseverin in this 
conformation will also be able to interact with actin through A4 and A6, whereas the A5 
surface is obscured. A single residue mutation in A4-A6 located at the predicted A4/actin 
interface completely abrogates actin sequestration. A model of calcium-free adseverin, 
constructed from the structure of gelsolin, predicts that in the absence of a gelsolin-like C-
terminal extension the interaction between A2 and A6 provides the steric inhibition to prevent 
interaction with F-actin. We propose that calcium binding to the N terminus of adseverin 
dominates the activation process to expose the F-actin binding site on A2. 
